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Preface
This dissertation describes the effects of perfusion flow and mechanical stimulation in
osteoblasts and osteoblast/endothelial cell co-cultures seeded in two-dimensions and on
three-dimensional scaffolds for use in tissue engineering. It explores the use of a novel
bioreactor for manipulating the mechanical environment of 3D cultures to maximize
osteogenic and angiogenic potential. Several chapters in this dissertation are in
preparation for publication and/or already in print in scientific journals.
Chapter 1 is an introduction with sufficient background and rationale for the
research proposed and performed, as well as the hypotheses and specific aims for
each research project.
Chapter 2 covers data generated while studying the effects of partitioning a
mechanical stimulus into bouts with rest periods inserted. This data did not show
significance, but represents the starting point for additional research comparing
mechanical stimulation in 2D vs. 3D and perfusion flow vs. static culture in 3D.
Chapter 3 describes the effects of mechanical stimulation on osteoblast cultures
in 2D and 3D and compares their gene expression profiles. This manuscript is
published in the Journal of Biomechanical Engineering (J Biomech Eng. 2010
Apr;132(4):041005). I performed the research and was the main author for this
publication.
Chapter 4 describes the effects of perfusion flow on 3D osteoblast cultures. This
study determined gene expression for several osteogenic and angiogenic genes
under varying treatments. This manuscript is being prepared for submission. I
performed the research and was the main author for this publication.
Chapter 5 covers data generated while running preliminary co-culture studies.
Experiments determined an appropriate ratio of endothelial cells to use in
conjunction with osteoblasts and also determined the effects of co-culture on
osteoblast-specific gene expression.
Chapter 6 investigated the pre-vascularization of 3D osteoblast cultures using
endothelial cells. This study utilized osteoblast/endothelial cell co-cultures in a
3D perfusion bioreactor, exploring the effects of perfusion flow vs. static
incubation. This manuscript is being prepared for submission. I performed the
research and was the main author for this publication.
Chapter 7 is a summary of all conclusions reached in this dissertation work.
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ABSTRACT
The delivery of oxygen, nutrients, and the removal of waste are essential for
cellular survival. Culture systems for 3D bone tissue engineering have addressed this
issue by utilizing perfusion flow bioreactors that stimulate osteogenic activity through the
delivery of oxygen and nutrients by low-shear fluid flow. It is also well established that
bone responds to mechanical stimulation, but may desensitize under continuous loading.
While perfusion flow and mechanical stimulation are used to increase cellular survival in
vitro, 3D tissue-engineered constructs face additional limitations upon in vivo
implantation. As it requires significant amounts of time for vascular infiltration by the
host, implants are subject to an increased risk of necrosis. One solution is to introduce
tissue-engineered bone that has been pre-vascularized through the co-culture of
osteoblasts and endothelial cells on 3D constructs.
It is unclear from previous studies: 1) how 3D bone tissue constructs will respond
to partitioned mechanical stimulation, 2) how gene expression compares in 2D and in 3D,
3) how co-cultures will affect osteoblast activity, and 4) how perfusion flow will affect
co-cultures of osteoblasts and endothelial cells. We have used an integrated approach to
address these questions by utilizing mechanical stimulation, perfusion flow, and a coculture technique to increase the success of 3D bone tissue engineering. We measured
gene expression of several osteogenic and angiogenic genes in both 2D and 3D (static
culture and mechanical stimulation), as well as in 3D cultures subjected to perfusion
flow, mechanical stimulation and partitioned mechanical stimulation. Finally, we cocultured osteoblasts and endothelial cells on 3D scaffolds and subjected them to longterm incubation in either static culture or under perfusion flow to determine changes in
gene expression as well as histological measures of osteogenic and angiogenic activity.
We discovered that 2D and 3D osteoblast cultures react differently to shear stress,
and that partitioning mechanical stimulation does not affect gene expression in our
model. Furthermore, our results suggest that perfusion flow may rescue 3D tissueengineered constructs from hypoxic-like conditions by reducing hypoxia-specific gene
expression and increasing histological indices of both osteogenic and angiogenic activity.
xii

Future research to elucidate the mechanisms behind these results may contribute to a
more mature bone-like structure that integrates more quickly into host tissue, increasing
the potential of bone tissue engineering.
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CHAPTER ONE
Introduction
Significance
There are over 1 million procedures that require the use of bone grafting each year
in the United States. Bone transplants are sometimes necessary for spinal fusion, fracture
healing, and defects resulting from trauma or disease (1-3). As the population continues
to age, the prevalence of degenerative disk disease and incidence of osteoporosis will also
increase, amplifying the incidence of bone grafting. Thus, the billion dollar market for
bone graft substitutes (BGS) will continue to rise. Currently, approximately 40% of all
grafting procedures utilize an autograft, which is harvested bone from a patient’s own
body. However, while autografts are currently the best available option for bone grafting,
the pain and morbidity associated with second surgeries combined with the limited
availability of autograft sources highlights the need for alternative grafting materials (13).
Several options are currently available as bone graft alternatives, including
allografts (donor bone), demineralized bone matrix (crushed allograft with mineral
removed), synthetic materials (polymeric or metallic scaffolds), growth factors (primarily
bone morphogenetic protein or BMP), and orthopedic stem cell products (OSCP – stem
cells combined with carrier). Ideally, any bone graft will; 1) provide scaffolding for new
bone tissue to grow into (osteoconductive), 2) induce host tissue to produce new bone
tissue (osteoinductive), and 3) supply a source for new tissue growth through osteoblasts
or mesenchymal stem cells (osteogenic) (3-6).

Of all bone graft alternatives, only

orthopedic stem cell products provide all three essential traits.
Three-dimensional (3D) bone tissue engineering embodies the OSCP category.
Bone tissue engineering is based on the use of a cell-seeded synthetic scaffold as a
grafting substitute. Typically, the construct is cultured outside of the body (in vitro) for a
period of time, allowing bone matrix to form within the porous scaffold. Upon in vivo
implantation, a successfully engineered bone graft will be accepted by the host tissue,
provide mechanical stability, and allow for remodeling of the construct by the host tissue
1

(1-3). While this approach is promising to be an effective therapy for skeletal defect
repair, one of the biggest limitations to overcome is the in vitro maintenance of cellular
viability within 3D constructs and in vivo vascular infiltration upon implantation.

Perfusion bioreactors
The delivery of oxygen, nutrients and the removal of waste are essential for
cellular survival in vivo and in vitro. Because of its poor diffusion capacity, oxygen
transport largely governs the production of 3D tissue cultures in vitro (7,8). In general,
diffusion of oxygen and nutrients is restricted to about 200 µm, which is approximately
the maximum distance between cells and capillaries in vivo (excepting cartilage)
(4,7,9,10).

As 3D in vitro tissue cultures lack oxygen- and nutrient-delivering

vasculature, they suffer from inadequate mass transport, limiting the culture of viable 3D
tissue (4,10).
The emergence of bioreactor technology has mitigated the transport limitations of
in vitro 3D bone culture. Many types of bioreactors have been developed, with most
falling into one of the following categories: rotating wall vessels, spinner flasks, or
perfusion flow systems. Each has its benefits and limitations. Spinner flasks have the
benefits of uniform cell seeding and center construct viability, but are limited in effect by
the formation of outer fibrous capsules due to high levels of fluid shear stresses. Rotating
wall vessels mitigate fibrous capsule formation by utilizing low magnitude fluid shear,
but also subject cells to microgravity conditions which are not physiologically relevant.
Of the three types of bioreactor, perhaps the most prevalent and broadest in scope is the
perfusion bioreactor. Utilizing fluid flow to deliver culture medium to the center of
cellular constructs, perfusion bioreactors have been modified to subject 3D cell-seeded
scaffolds to a wide range of shear stresses under a variety of waveforms. In addition to
being very adaptable, perfusion bioreactors have also been successfully used to create
commercially viable engineered tissue (11).
Perfusion bioreactors deliver culture medium to cell-seeded porous scaffolds with
the primary goal of improving chemotransport.

Perfusion flow increases cellular

infiltration and viability within 3D scaffolds and increases the level of oxygen transport
(7,12-16). This leads to up-regulation in gene expression (12,14,17), increases in protein
2

production (13,16,18-21), and enhanced calcium deposition (13,19,22-24) in osteoblastseeded scaffolds. Taken together, it is clear that there is great potential for the use
perfusion bioreactors in 3D bone tissue engineering.
In general, perfusion bioreactors utilize low rates of fluid flow, maintaining fluid
shear stresses much lower than physiological levels associated with mechanical loading
(25).

However, studies also show that increasing perfusion flow rate up-regulates

osteogenic gene expression and matrix production, suggesting higher quality tissue
formation. For example, osteopontin expression was directly correlated to the magnitude
of perfusion flow in marrow stromal osteoblasts (13), PGE2 production was enhanced in
osteoblasts by oscillatory shear stress (14,18), and mineralized matrix production
increased with increasing shear (13,19). These 3D studies highlight the importance of a
mechanically-regulated in vitro environment.

Effects of mechanical stimulation on bone
It is well established that bone responds to its mechanical environment both in
vivo and in vitro (18,26-30). In vivo, mechanical loading increases bone volume (31),
bone strength (30,32), and bone formation rate (33).

Furthermore, in vivo loading

increases the gene expression of vital matrix proteins such as osteocalcin (OCN),
collagen 1 (Col 1), and alkaline phosphatase (ALP) (34,35).

In general, excessive

mechanical loading causes bone formation, and reduced loading activates bone
resorption.
The

adaptation

of

bone

to

mechanical

loading

is

attributed

to

mechanotransduction, which is the conversion of mechanical stimuli into biochemical
responses. However, the mechanisms behind this conversion are unclear. Electric fields,
matrix strains, pressure gradients, and fluid shear stresses have all been considered as
possible mechanical stimuli responsible for bone adaptation (26). One of the most
popular theories suggests that as strains are imposed on bone, extracellular fluid is forced
through the network of canaliculi and lacunae, acting as the primary stimulus behind
osteocyte mechanosensation (36,37).

Thus, fluid flow may serve as the prominent

mediator in bone modeling, remodeling, and repair.
3

Historically, in vitro cultures have played a key role in the study of bone
mechanobiology, with fluid flow remaining one of the most well studied stimuli. The
vast majority of in vitro work has been done in two dimensions (2D), where magnitude,
waveform, and rate of shear stress have proven to be important determinants of
mechanically-induced gene expression in bone cells (38-43). Steady high shear stresses
of 1-2 Pa are common in 2D studies, as predictions suggest these values to be within the
range seen by bone cells in vivo under conditions of mechanical loading (25) . This highshear fluid flow enhances osteogenic activity through the mediation of proliferation,
differentiation, and matrix deposition (39,44-49).
One limitation with in vitro models is that 2D experiments are performed on flat
surfaces, which do not mimic in vivo 3D architecture. As a result, 2D in vitro models do
not provide physiological environments for mechanotransduction studies. Bone cells
have been shown to react differently in 2D and 3D environments (50-53). For example,
measures of both osteogenic and angiogenic activity were up-regulated in 3D cultures of
bone cells compared to those cultured in 2D (54-56). Considering this, it is clear that 2D
models do not always accurately represent what will occur in 3D conditions. Mechanical
stimulation in 3D osteoblast cultures has not been studied extensively. However, there is
literature showing that perfusion flow increases matrix production (12,18,56),
mineralization (13,19,57), and late stage osteogenic gene expression (12,14) in
osteoblastic cells cultured on 3D scaffolds. Since the perfusion flow utilized in the these
studies resulted in shear stresses well below those experienced in vivo (25), there remains
little data on the effects of physiologically-relevant mechanical stimulation in 3D (18,58).
Thus, one of the aims of this dissertation work is to determine if flow-induced shear
stress mediates gene expression similarly in osteoblast-like cells cultured in 2D and 3D
environments.
While it is clear that mechanical stimulation affects bone both in vivo and in vitro,
there is evidence that osteoblasts subjected to continuous mechanical stimulation may
contain mechanisms that desensitize them to further loading after a certain period (32,5962). In vivo work has shown that bone cells will accommodate to loading conditions after
time, rendering continued loading ineffective (61). However, research has also shown
that mechanosensitivity can be regained with rest; rat tibias responded more
4

osteogenically to shorter, partitioned bouts of mechanical stimulus as compared to a
constant, prolonged bout (32). In vitro work has confirmed these studies, demonstrating
that rest periods between bouts of mechanical stimulus allow osteoblastic cells to regain
their mechanosensitivity (21,42,62).

Taken together, these results suggest that it is

possible to manipulate the mechanical environment of cells to produce a desired
response, allowing scientists to maximize osteogenic potential. Therefore, the aims of
this dissertation work include the study of partitioned mechanical stimulation in 3D
cultures of osteoblast-like cells. This not only has direct clinical implications, but also
presents in vitro opportunities to condense the culture time needed to produce highquality tissue-engineered bone.

Vascularization of Bone
Over 200 years ago, Hunter predicted the importance of blood vessels to bone
development and fracture repair (63,64). Since then, many studies have shown that
proper vascularization is critical for successful bone growth and fracture healing
(36,63,64). The vasculature provides bone tissue with oxygen, nutrients, and growth
factors, as well as the removal of metabolic waste products.

Without appropriate

vascularization, bone tissue would face limited growth and hypoxia (64), decreased bone
formation (65), and improper fracture healing (66).
As bone tissue-engineering is emerging as a potential source of tissue implants,
vascularization must be considered as it is critical for graft acceptance (67-72). One of
the major limitations of tissue-engineered bone is that once implanted in vivo, significant
amounts of time are required for vascular integration. Current methods rely on the ingrowth of vasculature from host tissue (68,70), which can lead to poor vascularization
and implant rejection (68). One solution to this clinical problem is to introduce tissueengineered bone that has been pre-vascularized by a rudimentary vascular system
(68,70,71,73,74). Approaches to this solution include the co-culture of bone cells and
endothelial cells on three-dimensional constructs.
Endothelial cells are major constituents of the vasculature that function as a barrier and
are capable of direct communication with adjacent tissue and circulating blood cells
(68,69,75-77). Bone is a highly vascularized tissue; haversian canals in cortical bone and
5

marrow spaces in trabecular bone are lined with capillary-rich endothelium.

As

haversian canals and trabeculae also contain bone lining cells (quiescent osteoblasts), the
intimate relationship between osteoblasts and endothelial cells is apparent.
It was once thought that endothelial cells were simply conduits for the transport of
nutrients and waste (75,78). Now, it is recognized that endothelial cells are actively
involved in bone growth, development, and maintenance. Moreover, communication
between the bone and vasculature is necessary for healthy bone, and angiogenesis and
osteogenesis are considered to be tightly coupled processes (63).

Endothelial cells

produce and secrete a number of mediators (e.g. NO, FGF, prostaglandins) that contribute
to the control of osteoblast activity.

Likewise, osteoblasts synthesize an array of

cytokines and growth factors (most notably vascular endothelial growth factor) that
influence endothelial cells (63,77,79).
There has been some success with co-culturing bone cells and endothelial cells to
overcome the lack of vasculature in tissue-engineered bone (68-71,73,74,80). These
studies have shown that not only will endothelial cells form a pre-vascular network
during co- culture (70,71,73), but also that endothelial cells can augment osteoblastic
activity when in direct contact with osteoblasts (69,70,73,77,81). Furthermore, recent
work has shown the in vivo integration of 3D co-cultures, with the formation of an
improved vascular network upon implantation (72,82-84).
While it is known that endothelial cells and osteoblasts share a positive synergy in
co-culture, many early systems utilized either static 2D cultures or a spheroidal 3D pellet
culture model that would not sustain mechanical loading as an implant, nor serve as an
osteoconductive scaffold for host integration. There is little data on the response of cocultures on a porous 3D scaffold, and less data on how a dynamic environment will affect
them. Therefore, the aims of this dissertation work include the study of osteoblast and
endothelial cell co-cultures on 3D scaffolds in a perfusion bioreactor.

6

Rationale, Hypotheses, and Specific Aims for Dissertation Research
Mechanical Stimulation in 3D
2D fluid flow studies have yielded an abundance of data clarifying cellular
signaling mechanisms following mechanical stimulation. Stimulation causes bone cells
to up-regulate NO, OPN, PGE2, and COX-2 (48,49,85-87), and the signaling pathways
responsible for these changes have also been studied (41,48,88) . While 2D studies are
valuable,

they

do

not

represent

a

physiologically-relevant

model

for

mechanotransduction. Since bone cells have been shown to react differently in 2D and
3D environments (50-53), it is important to consider 3D models as responses to
mechanical stimulation may be different. Although perfusion bioreactors are widely used
to culture bone in 3D, these studies use flow that is orders of magnitude lower than what
is considered to be mechanical stimulation (12,13,19,23,57,89).

Additionally, most

studies are interested in long term responses to perfusion flow, such as matrix production
and calcium deposition. Thus, there remains a paucity of data on early responses to
perfusion flow and the effects of mechanical stimulation on 3D cultures. Furthermore,
while partitioned loading schemes have been tested both in vivo and in 2D in vitro
studies (32,46,47,62), it is not known how 3D cultures will respond. Therefore, the goals
of this study were: 1) determine if flow-induced shear stress mediates gene expression
similarly in osteoblast-like cells cultured in 2D and 3D environments, and 2) determine
whether subjecting 3D cultures to partitioned mechanical stimulation will provoke a
distinct osteogenic response as compared to continuous stimulation, perfusion flow or
static culture.

Hypothesis I:

Osteoblasts cultured in 3D will up-regulate mRNA levels of

osteogenic-specific genes when subjected to partitioned mechanical stimulation as
compared to mechanical stimulation, perfusion flow, or static culture.
Specific Aim – Determine gene expression for osteogenic and angiogenic activity in 2D
and 3D cultures subjected to mechanical stimulation, and in 3D cultures under static,
perfusion, mechanical, and partitioned mechanical treatments.

7

Co-culture in 2D and 3D
The ultimate goal of bone tissue engineering is to produce usable bone in vitro
that will remain viable upon implantation and fully integrate with the host tissue. Since it
requires time for host vasculature to infiltrate implanted tissue, efforts have been made to
circumvent this issue by pre-vascularizing tissue engineered bone (68,70,71,73,74). One
approach is to co-culture bone and endothelial cells on 3D constructs prior to
implantation with the hope that a rudimentary vascular-like network will form,
accelerating vascular integration with host tissue. To date, there has been some success
with co-culturing bone cells and endothelial cells to overcome the lack of vasculature in
tissue-engineered bone (68-71,73,74,80). These studies have shown that not only will
endothelial cells form a pre-vascular network during co- culture (70,71,73), but also that
endothelial cells can augment osteoblastic activity when in direct contact with osteoblasts
(69,70,73,77,81). However, most co-culture systems utilize a spheroidal culture model
that would not sustain mechanical loading as an implant, nor serve as an osteoconductive
scaffold for host integration. Since implants would experience a mechanical load in vivo,
a 3D model that can withstand loads is desirable.

It is not known whether an

osteoblast/endothelial cell co-culture seeded onto a porous scaffold will change
osteogenic or angiogenic gene expression compared to osteoblast cultures alone.

Hypothesis II:

Osteoblast/endothelial cell co-cultures will result in higher

expression of osteogenic and angiogenic genes as compared to osteoblasts cultured
alone in 3D environments. Furthermore, endothelial cells will form a vascular-like
network when in co-culture.
Specific Aim: Quantify gene expression of osteogenic and angiogenic activity over time.
Real-time PCR will quantify mRNA levels of bone markers (type 1 collagen,
osteopontin, osteocalcin, alkaline phosphatase, Cox-2) and angiogenic markers (VEGF
and M-CSF). The ratio of endothelial cells to osteoblasts that produces the greatest
increase in gene expression will also be determined.

8

Co-culture in a perfusion bioreactor
While co-cultures have proven to form vascular-like networks in addition to upregulating osteogenic activity, there is no literature describing the dynamic culture of a
co-culture system. Thus, it is not known how a co-culture model will respond to the
dynamic environment provided by a perfusion bioreactor. Since it is well known that
fluid flow activates both osteoblasts and endothelial cells (63,77,79,90), we propose that
a co-culture model under perfusion flow will increase osteogenic and angiogenic gene
expression.

Furthermore, endothelial cells have also been known to form tube-like

structures more quickly when exposed to fluid flow (91). So, in addition to increases in
gene expression, we also expect to see an increase in tube-like formation in samples
cultured under fluid flow. This work will help elucidate the contributions of endothelial
cells to osteoblastic gene activity, as well as the effects that a dynamic environment has
on the formation of a vascular network in co-cultures. This will be the first study of
osteoblast and endothelial cell co-cultures in a perfusion bioreactor.

Hypothesis III: Osteoblast/endothelial cell co-cultures subjected to perfusion flow
will increase osteogenic activity compared to static cultures. In addition, culture in
the perfusion bioreactor will increase the length and number of endothelial tube-like
formations.
Specific Aim: Quantify gene expression of osteogenic and angiogenic activity over time.
Real-time PCR will quantify mRNA levels of VEGF, M-CSF, type 1 collagen,
osteopontin, osteocalcin, alkaline phosphatase, and Cox-2. Osteoid deposition and vessel
formation over time with and without perfusion flow will also be quantified.

9

References
1.

Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG 1996 Evolution of
bone transplantation: molecular, cellular and tissue strategies to engineer human
bone. Biomaterials 17(2):175-85.

2.

Bauer TW 2007 An overview of the histology of skeletal substitute materials.
Arch Pathol Lab Med 131(2):217-24.

3.

Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA 2007 Cell-Based Bone
Tissue Engineering. PLoS Med 4(2):e9.

4.

Muschler GF, Nakamoto C, Griffith LG 2004 Engineering principles of clinical
cell-based tissue engineering. J Bone Joint Surg Am 86-A(7):1541-58.

5.

Langer R, Vacanti JP, Vacanti CA, Atala A, Freed LE, Vunjak-Novakovic G
1995 Tissue engineering: biomedical applications. Tissue Eng 1(2):151-61.

6.

Galletti PM, Hellman KB, Nerem RM 1995 Tissue engineering: from basic
science to products: a preface. Tissue Eng 1(2):147-9.

7.

Volkmer E, Drosse I, Otto S, Stangelmayer A, Stengele M, Kallukalam BC,
Mutschler W, Schieker M 2008 Hypoxia in static and dynamic 3D culture
systems for tissue engineering of bone. Tissue Eng Part A 14(8):1331-40.

8.

Malda J, Klein TJ, Upton Z 2007 The roles of hypoxia in the in vitro engineering
of tissues. Tissue Eng 13(9):2153-62.

9.

Arkudas A, Beier JP, Heidner K, Tjiawi J, Polykandriotis E, Srour S, Sturzl M,
Horch RE, Kneser U 2007 Axial prevascularization of porous matrices using an
arteriovenous loop promotes survival and differentiation of transplanted
autologous osteoblasts. Tissue Eng 13(7):1549-60.

10.

Griffith CK, Miller C, Sainson RC, Calvert JW, Jeon NL, Hughes CC, George SC
2005 Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11(12):257-66.

11.

Chen HC, Hu YC 2006 Bioreactors for tissue engineering. Biotechnol Lett
28(18):1415-23.

12.

Cartmell SH, Porter BD, Garcia AJ, Guldberg RE 2003 Effects of medium
perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue
Eng 9(6):1197203.

13.

Bancroft GN, Sikavitsas VI, van den Dolder J, Sheffield TL, Ambrose CG, Jansen
JA, Mikos AG 2002 Fluid flow increases mineralized matrix deposition in 3D
10

perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc
Natl Acad Sci U S A 99(20):12600-5.
14.

Jaasma MJ, O'Brien FJ 2008 Mechanical stimulation of osteoblasts using steady
and dynamic fluid flow. Tissue Eng Part A 14(7):1213-23.

15.

Du D, Furukawa KS, Ushida T 2009 3D culture of osteoblast-like cells by
unidirectional or oscillatory flow for bone tissue engineering. Biotechnol Bioeng
102(6):1670-8.

16.

Li D, Tang T, Lu J, Dai K 2009 Effects of flow shear stress and mass transport on
the construction of a large-scale tissue-engineered bone in a perfusion bioreactor.
Tissue Eng Part A 15(10):2773-83.

17.

Holtorf HL, Jansen JA, Mikos AG 2006 Modulation of cell differentiation in bone
tissue engineering constructs cultured in a bioreactor. Adv Exp Med Biol
585:225-41.

18.

Vance J, Galley S, Liu DF, Donahue SW 2005 Mechanical stimulation of MC3T3
osteoblastic cells in a bone tissue-engineering bioreactor enhances prostaglandin
E2 release. Tissue Eng 11(11-12):1832-9.

19.

Sikavitsas VI, Bancroft GN, Holtorf HL, Jansen JA, Mikos AG 2003 Mineralized
matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases
with increasing fluid shear forces. Proc Natl Acad Sci U S A 100(25):14683-8.

20.

Wang Y, Uemura T, Dong J, Kojima H, Tanaka J, Tateishi T 2003 Application of
perfusion culture system improves in vitro and in vivo osteogenesis of bone
marrow-derived osteoblastic cells in porous ceramic materials. Tissue Eng
9(6):1205-14.

21.

Plunkett NA, Partap S, O'Brien FJ Osteoblast response to rest periods during
bioreactor culture of collagen-glycosaminoglycan scaffolds. Tissue Eng Part A
16(3):94351.

22.

Zhao F, Chella R, Ma T 2007 Effects of shear stress on 3-D human mesenchymal
stem cell construct development in a perfusion bioreactor system: Experiments
and hydrodynamic modeling. Biotechnol Bioeng 96(3):584-95.

23.

Datta N, Pham QP, Sharma U, Sikavitsas VI, Jansen JA, Mikos AG 2006 In vitro
generated extracellular matrix and fluid shear stress synergistically enhance 3D
osteoblastic differentiation. Proc Natl Acad Sci U S A 103(8):2488-93.

24.

Holtorf HL, Datta N, Jansen JA, Mikos AG 2005 Scaffold mesh size affects the
osteoblastic differentiation of seeded marrow stromal cells cultured in a flow
perfusion bioreactor. J Biomed Mater Res A 74(2):171-80.
11

25.

Weinbaum S, Cowin SC, Zeng Y 1994 A model for the excitation of osteocytes
by mechanical loading-induced bone fluid shear stresses. J Biomech 27(3):33960.

26.

Rubin J, Rubin C, Jacobs CR 2006 Molecular pathways mediating mechanical
signaling in bone. Gene 367:1-16.

27.

Iqbal J, Zaidi M 2005 Molecular regulation of mechanotransduction. Biochem
Biophys Res Commun 328(3):751-5.

28.

Weiss S, Zimmermann G, Baumgart R, Kasten P, Bidlingmaier M, Henle P 2005
Systemic regulation of angiogenesis and matrix degradation in bone regeneration-distraction osteogenesis compared to rigid fracture healing. Bone 37(6):781-90.

29.

Li G, Simpson AH, Kenwright J, Triffitt JT 1999 Effect of lengthening rate on
angiogenesis during distraction osteogenesis. J Orthop Res 17(3):362-7.

30.

Robling AG, Castillo AB, Turner CH 2006 Biomechanical and molecular
regulation of bone remodeling. Annu Rev Biomed Eng 8:455-98.

31.

van der Meulen MC, Morgan TG, Yang X, Baldini TH, Myers ER, Wright TM,
Bostrom MP 2006 Cancellous bone adaptation to in vivo loading in a rabbit
model. Bone 38(6):871-7.

32.

Robling AG, Burr DB, Turner CH 2000 Partitioning a daily mechanical stimulus
into discrete loading bouts improves the osteogenic response to loading. J Bone
Miner Res 15(8):1596-602.

33.

Schriefer JL, Warden SJ, Saxon LK, Robling AG, Turner CH 2005 Cellular
accommodation and the response of bone to mechanical loading. J Biomech
38(9):1838-45.

34.

Moalli MR, Caldwell NJ, Patil PV, Goldstein SA 2000 An in vivo model for
investigations of mechanical signal transduction in trabecular bone. J Bone Miner
Res 15(7):1346-53.

35.

Pavlin D, Zadro R, Gluhak-Heinrich J 2001 Temporal pattern of stimulation of
osteoblast-associated genes during mechanically-induced osteogenesis in vivo:
early responses of osteocalcin and type I collagen. Connect Tissue Res 42(2):13548.

36.

John P. Bilezikian LGR, Gideon A. Rodan 2002 Principles of Bone Biology. In:
Bilezikian R, Rodan (ed.) Principles of Bone Biology, 2nd ed., vol. 1 and 2.
Academic Press, San Diego, pp 1700.
12

37.

Cowin SC, Moss-Salentijn L, Moss ML 1991 Candidates for the mechanosensory
system in bone. J Biomech Eng 113(2):191-7.

38.

Li YJ, Batra NN, You L, Meier SC, Coe IA, Yellowley CE, Jacobs CR 2004
Oscillatory fluid flow affects human marrow stromal cell proliferation and
differentiation. J Orthop Res 22(6):1283-9.

39.

You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR 2001
Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium
mobilization and activation of mitogen-activated protein kinase in MC3T3-E1
osteoblasts. J Biol Chem 276(16):13365-71.

40.

Ponik SM, Triplett JW, Pavalko FM 2007 Osteoblasts and osteocytes respond
differently to oscillatory and unidirectional fluid flow profiles. J Cell Biochem
100(3):794-807.

41.

Wu CC, Li YS, Haga JH, Wang N, Lian IY, Su FC, Usami S, Chien S 2006 Roles
of MAP kinases in the regulation of bone matrix gene expressions in human
osteoblasts by oscillatory fluid flow. J Cell Biochem 98(3):632-41.

42.

Batra NN, Li YJ, Yellowley CE, You L, Malone AM, Kim CH, Jacobs CR 2005
Effects of short-term recovery periods on fluid-induced signaling in osteoblastic
cells. J Biomech 38(9):1909-17.

43.

Sittichockechaiwut A, Scutt AM, Ryan AJ, Bonewald LF, Reilly GC 2009 Use of
rapidly mineralising osteoblasts and short periods of mechanical loading to
accelerate matrix maturation in 3D scaffolds. Bone 44(5):822-9.

44.

Chen NX, Ryder KD, Pavalko FM, Turner CH, Burr DB, Qiu J, Duncan RL 2000
Ca(2+) regulates fluid shear-induced cytoskeletal reorganization and gene
expression in osteoblasts. Am J Physiol Cell Physiol 278(5):C989-97.

45.

Donahue SW, Jacobs CR, Donahue HJ 2001 Flow-induced calcium oscillations in
rat osteoblasts are age, loading frequency, and shear stress dependent. Am J
Physiol Cell Physiol 281(5):C1635-41.

46.

Donahue TL, Haut TR, Yellowley CE, Donahue HJ, Jacobs CR 2003
Mechanosensitivity of bone cells to oscillating fluid flow induced shear stress
may be modulated by chemotransport. J Biomech 36(9):1363-71.

47.

Jacobs CR, Yellowley CE, Davis BR, Zhou Z, Cimbala JM, Donahue HJ 1998
Differential effect of steady versus oscillating flow on bone cells. J Biomech
31(11):969-76.

13

48.

Wadhwa S, Choudhary S, Voznesensky M, Epstein M, Raisz L, Pilbeam C 2002
Fluid flow induces COX-2 expression in MC3T3-E1 osteoblasts via a PKA
signaling pathway. Biochem Biophys Res Commun 297(1):46-51.

49.

Wadhwa S, Godwin SL, Peterson DR, Epstein MA, Raisz LG, Pilbeam CC 2002
Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is
dependent on an extracellular signal-regulated kinase signaling pathway. J Bone
Miner Res 17(2):266-74.

50.

Liu H, Lin J, Roy K 2006 Effect of 3D scaffold and dynamic culture condition on
the global gene expression profile of mouse embryonic stem cells. Biomaterials
27(36):5978-89.

51.

Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ 2009
Cancer cell angiogenic capability is regulated by 3D culture and integrin
engagement. Proc Natl Acad Sci U S A 106(2):399-404.

52.

Byrne EM, Farrell E, McMahon LA, Haugh MG, O'Brien FJ, Campbell VA,
Prendergast PJ, O'Connell BC 2008 Gene expression by marrow stromal cells in a
porous collagen-glycosaminoglycan scaffold is affected by pore size and
mechanical stimulation. J Mater Sci Mater Med 19(11):3455-63.

53.

Farrell E, Byrne EM, Fischer J, O'Brien FJ, O'Connell BC, Prendergast PJ,
Campbell VA 2007 A comparison of the osteogenic potential of adult rat
mesenchymal stem cells cultured in 2-D and on 3-D collagen glycosaminoglycan
scaffolds. Technol Health Care 15(1):19-31.

54.

Hishikawa K, Miura S, Marumo T, Yoshioka H, Mori Y, Takato T, Fujita T 2004
Gene expression profile of human mesenchymal stem cells during osteogenesis in
three-dimensional thermoreversible gelation polymer. Biochem Biophys Res
Commun 317(4):1103-7.

55.

Helmke C 1999 Factors affecting bone cell growth and differentiation under
differing culture conditions, vol. Master of Arts. Rice University, Houston, pp 75.

56.

Jarrahy R, Huang W, Rudkin GH, Lee JM, Ishida K, Berry MD, Sukkarieh M,
Wu BM, Yamaguchi DT, Miller TA 2005 Osteogenic differentiation is inhibited
and angiogenic expression is enhanced in MC3T3-E1 cells cultured on threedimensional scaffolds. Am J Physiol Cell Physiol 289(2):C408-14.

57.

Holtorf HL, Jansen JA, Mikos AG 2005 Flow perfusion culture induces the
osteoblastic differentiation of marrow stroma cell-scaffold constructs in the
absence of dexamethasone. J Biomed Mater Res A 72(3):326-34.

14

58.

Tanaka SM, Sun HB, Roeder RK, Burr DB, Turner CH, Yokota H 2005
Osteoblast responses one hour after load-induced fluid flow in a threedimensional porous matrix. Calcif Tissue Int 76(4):261-71.

59.

Robling AG, Burr DB, Turner CH 2001 Recovery periods restore
mechanosensitivity to dynamically loaded bone. J Exp Biol 204(Pt 19):3389-99.

60.

Robling AG, Turner CH 2002 Mechanotransduction in bone: genetic effects on
mechanosensitivity in mice. Bone 31(5):562-9.

61.

Saxon LK, Robling AG, Alam I, Turner CH 2005 Mechanosensitivity of the rat
skeleton decreases after a long period of loading, but is improved with time off.
Bone 36(3):454-64.

62.

Donahue SW, Donahue HJ, Jacobs CR 2003 Osteoblastic cells have refractory
periods for fluid-flow-induced intracellular calcium oscillations for short bouts of
flow and display multiple low-magnitude oscillations during long-term flow. J
Biomech 36(1):35-43.

63.

Carano RA, Filvaroff EH 2003 Angiogenesis and bone repair. Drug Discov
Today 8(21):980-9.

64.

Glowacki J 1998 Angiogenesis in fracture repair. Clin Orthop Relat Res (355
Suppl):S82-9.

65.

Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B,
Mallmann B, Eisenmenger W, Gilg T 1987 Changes in trabecular bone,
hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis,
and old age: a comparative histomorphometric study. Bone 8(3):157-64.

66.

Hausman MR, Schaffler MB, Majeska RJ 2001 Prevention of fracture healing in
rats by an inhibitor of angiogenesis. Bone 29(6):560-4.

67.

Kanczler JM, Oreffo RO 2008 Osteogenesis and angiogenesis: the potential for
engineering bone. Eur Cell Mater 15:100-14.

68.

Choong CS, Hutmacher DW, Triffitt JT 2006 Co-culture of Bone Marrow
Fibroblasts and Endothelial Cells on Modified Polycaprolactone Substrates for
Enhanced Potentials in Bone Tissue Engineering. Tissue Eng.

69.

Stahl A, Wenger A, Weber H, Stark GB, Augustin HG, Finkenzeller G 2004 Bidirectional cell contact-dependent regulation of gene expression between
endothelial cells and osteoblasts in a three-dimensional spheroidal coculture
model. Biochem Biophys Res Commun 322(2):684-92.

15

70.

Wenger A, Kowalewski N, Stahl A, Mehlhorn AT, Schmal H, Stark GB,
Finkenzeller G 2005 Development and characterization of a spheroidal coculture
model of endothelial cells and fibroblasts for improving angiogenesis in tissue
engineering. Cells Tissues Organs 181(2):80-8.

71.

Unger RE, Sartoris A, Peters K, Motta A, Migliaresi C, Kunkel M, Bulnheim U,
Rychly J, Kirkpatrick CJ 2007 Tissue-like self-assembly in cocultures of
endothelial cells and osteoblasts and the formation of microcapillary-like
structures on three-dimensional porous biomaterials. Biomaterials 28(27):396576.

72.

Santos MI, Reis RL Vascularization in bone tissue engineering: physiology,
current strategies, major hurdles and future challenges. Macromol Biosci
10(1):12-27.

73.

Rouwkema J, de Boer J, Van Blitterswijk CA 2006 Endothelial cells assemble
into a 3-dimensional prevascular network in a bone tissue engineering construct.
Tissue Eng 12(9):2685-93.

74.

Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R, Amedee J
2002 Effect of HUVEC on human osteoprogenitor cell differentiation needs
heterotypic gap junction communication. Am J Physiol Cell Physiol 282(4):C77585.

75.

Streeten EA, Brandi ML 1990 Biology of bone endothelial cells. Bone Miner
10(2):85-94.

76.

Brandi ML, Collin-Osdoby P 2006 Vascular biology and the skeleton. J Bone
Miner Res 21(2):183-92.

77.

Villars F, Bordenave L, Bareille R, Amedee J 2000 Effect of human endothelial
cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell
Biochem 79(4):672-85.

78.

Collin-Osdoby P 1994 Role of vascular endothelial cells in bone biology. J Cell
Biochem 55(3):304-9.

79.

Street J, Bao M, deGuzman L, Bunting S, Peale FV, Jr., Ferrara N, Steinmetz H,
Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA,
Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by
promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A
99(15):9656-61.

80.

Akita S, Tamai N, Myoui A, Nishikawa M, Kaito T, Takaoka K, Yoshikawa H
2004 Capillary vessel network integration by inserting a vascular pedicle
16

enhances bone formation in tissue-engineered bone using interconnected porous
hydroxyapatite ceramics. Tissue Eng 10(5-6):789-95.
81.

Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP 2008 Evaluation of
VEGF-mediated signaling in primary human cells reveals a paracrine action for
VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol
214(2):537-44.

82.

Steffens L, Wenger A, Stark GB, Finkenzeller G 2009 In vivo engineering of a
human vasculature for bone tissue engineering applications. J Cell Mol Med
13(9B):3380-6.

83.

Yu H, VandeVord PJ, Mao L, Matthew HW, Wooley PH, Yang SY 2009
Improved tissue-engineered bone regeneration by endothelial cell mediated
vascularization. Biomaterials 30(4):508-17.

84.

Fidkowski C, Kaazempur-Mofrad MR, Borenstein J, Vacanti JP, Langer R, Wang
Y 2005 Endothelialized microvasculature based on a biodegradable elastomer.
Tissue Eng 11(1-2):302-9.

85.

Bacabac RG, Smit TH, Mullender MG, Dijcks SJ, Van Loon JJ, Klein-Nulend J
2004 Nitric oxide production by bone cells is fluid shear stress rate dependent.
Biochem Biophys Res Commun 315(4):823-9.

86.

Mullender MG, Dijcks SJ, Bacabac RG, Semeins CM, Van Loon JJ, KleinNulend J 2006 Release of nitric oxide, but not prostaglandin E2, by bone cells
depends on fluid flow frequency. J Orthop Res 24(6):1170-7.

87.

Reich KM, Frangos JA 1991 Effect of flow on prostaglandin E2 and inositol
trisphosphate levels in osteoblasts. Am J Physiol 261(3 Pt 1):C428-32.

88.

Bakker AD, Klein-Nulend J, Burger EH 2003 Mechanotransduction in bone cells
proceeds via activation of COX-2, but not COX-1. Biochem Biophys Res
Commun 305(3):677-83.

89.

Goldstein AS, Juarez TM, Helmke CD, Gustin MC, Mikos AG 2001 Effect of
convection on osteoblastic cell growth and function in biodegradable polymer
foam scaffolds. Biomaterials 22(11):1279-88.

90.

Ozawa N, Shichiri M, Iwashina M, Fukai N, Yoshimoto T, Hirata Y 2004
Laminar shear stress up-regulates inducible nitric oxide synthase in the
endothelium. Hypertens Res 27(2):93-9.

91.

Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A, Ando J
2003 Proliferation, differentiation, and tube formation by endothelial progenitor
cells in response to shear stress. J Appl Physiol 95(5):2081-8.
17

CHAPTER TWO
Partitioned Mechanical Stimulation
Introduction
Three-dimensional (3D) bone tissue engineering is promising to be an effective
therapy for skeletal defect repair. However, diffusional constraints subject 3D cultures to
limited cellular viability in the center of larger constructs (1,2).

Consequently,

researchers have developed perfusion bioreactors which deliver nutrients and oxygen to
3D scaffolds, as well as remove waste (1-5). Indeed, perfusion flow increases cellular
viability within the center of 3D scaffolds (1,2). Although the use of perfusion flow is
promising, high-shear flow rates have been shown to reduce cell number on 3D scaffolds
due to increasing shear stress (1-3).
Fluid shear is recognized as a major mediator of osteogenic activity, and has
potential to enhance bone tissue engineering procedures (2,6,7). Shear stress enhances
osteogenic activity through the mediation of osteoblast proliferation, differentiation,
matrix production, apoptosis, and angiogenic gene expression of bone cells.

The

magnitude, waveform, and rate of shear stress are important determinants of
mechanically-induced gene expression in bone cells. Fluid flow studies involve loading
regimes that include various flow types over several hours of stimulation. Steady shear
stresses of 1-2 Pa are common, as predictions suggest these values to be within the range
seen by bone cells in vivo (8) .
While mechanical stimulation can improve osteogenic activity, there is evidence
that osteoblasts subjected to continuous mechanical stimulation may contain mechanisms
that desensitize them to further loading after a certain period. Rat tibias loaded in fourpoint bending responded more osteogenically to shorter, partitioned bouts of mechanical
stimulus as compared to less frequent, prolonged bouts (9). Furthermore, in vitro studies
demonstrate that rest periods between bouts of mechanical stimulus allow osteoblastic
cells to regain their mechanosensitivity (10,11).
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3D perfusion cultures have recently provided valuable data concerning the
disparate effects of varied shear rate on bone growth (1-4,12-15). Osteoblasts exposed to
varying rates of perfusion (0.01-1.0 ml/min) had the greatest cellular viability and
proliferation at the lowest flow rates (1). On the other hand, gene expression of several
bone-specific proteins (OCN, OPN, ALP) increased as the flow rate increased. Taken
together, this suggests that high rates of flow up-regulate gene expression, but reduce
cellular viability when applied continuously.
In the present study, we propose to utilize both high and low rates of flow in a
perfusion bioreactor to determine whether intermittent bouts of fluid shear can mediate
growth-related, angiogenic, and apoptotic gene expression in osteoblasts seeded in 3D
and exposed to continuous perfusion flow . Using low-shear perfusion flow to maintain
cell-viability and high-shear flow as mechanical stimulation, we hypothesize that MC3T3
pre-osteoblast-seeded calcium phosphate scaffolds cultured in a 3D perfusion bioreactor
will elicit a higher osteogenic response when exposed to intermittent mechanical loading
as compared to a single bout of mechanical stimulation, perfusion flow alone, or static
cultures.

Materials and Methods
Cell Culture
Mouse osteoblast-like cells (MC3T3-E1 subclone 14, ATCC, Manassas, VA)
between passage numbers 20 and 26 were cultured in alpha-MEM (Invitrogen,
Carlsband, CA) with 10% FBS (Hyclone, Logan, UT) and 1% pen/strep (Cellgro,
Herndon, VA).

Once cells reached ~70% confluency, they were trypsinized, re-

suspended in culture medium, and statically seeded onto 3D calcium phosphate scaffolds
(1,000,000 cells/scaffold) (BD Biosciences, San Jose, CA). The scaffolds have an
interconnected porosity of ~ 60% with an average pore size of 200-400 microns. This is
comparable to trabecular bone (50-90% porosity, 500-1500 micron pore size (16)), and
within the range suggested to be optimal for bone regeneration (150 – 650 microns) in
porous scaffolds (17). Samples were then incubated for 1 hour to allow cell adhesion,
and were covered with media and incubated for 24 hours before experiments began.
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Mechanical Loading in 3D
A custom perfusion bioreactor was used to mechanically stimulate osteoblasts on
calcium phosphate scaffolds. Each bioreactor chamber consists of a top and bottom
aluminum block, between which a polycarbonate block is secured (Fig. 1). A 6-mm hole

Figure 1 - Bioreactor setup for high-shear flow superimposed over low-shear flow. A syringe pump
and a linear actuator were both in line with the bioreactor. Net fluid flow equaled the rate of the
syringe pump. See text for more details.
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was drilled out of the polycarbonate block to fit a porous calcium phosphate scaffold 5mm in diameter and 3.5-mm in height (BD Biosciences, Bedford, MA). A 4-mm hole
was drilled through the center of all three blocks to allow fluid flow through the scaffold.
Grooves were machined around both the hole and the space on each side of the
polycarbonate block to fit a #11 Viton O-ring (Allorings, Hampton Falls, NH). A 1/8th
inch barbed pipe connector was threaded into both the top and bottom aluminum blocks
and connected to 1/8th inch silicone tubing (Harvard Apparatus, Holliston, MA). The
silicone tubing used is permeable to both CO2 and O2, so that cells were permitted
adequate gas exchange. Tubing connected the top of the chamber to a 140 ml syringe
fluid reservoir and the bottom of the chamber to a three-way valve. This valve was
connected to both a syringe pump (Harvard Apparatus) and an electromagnetic linear
actuator (Linmot, Delavan, WI). The syringe pump provided constant perfusion flow,
while the linear actuator superimposed oscillatory flow at a higher shear rate.

Once

ready for experimentation, scaffolds were placed into the bioreactor chambers and
connected into the flow circuit.

Experimental Design
My first 2 experiments were major experiments that were designed to establish
the effects of partitioning mechanical stimulation on gene expression in osteoblasts
seeded onto 3D scaffolds, and to compare those effects with single-bout mechanical
stimulation as well as perfusion flow and static culture. The experiments were also
designed to compare different incubation methods (static vs. perfusion). Following the
first experiment, changes were made in the variable parameters (flow rates) to increase
cellular response. The general design of the experiment did not change.
Experimental Design – Experiment 1
There were six experimental groups in addition to a static control and a vehicle
control (eight total groups). The six experimental groups consisted of three loading
treatments with two types of incubation after loading; a static incubation group and a
perfusion incubation group. Each group contained 4 samples. Treatment groups can be
seen in Table 1.
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60 min
Oscillatory Flow 4 - 15 min bouts Oscillatory
Flow with 15 min Rest
Superimposed
60 min
Perfusion Flow on Perfusion
Periods between
Static
Vehicle
Perfusion
High-shear
Partitioned
High-shear
Perfusion
High-shear
Partitioned
High-shear

x
x
x
x
x

x
x

Static
Incubation
x
x
x
x

Perfusion
Incubation

x

x
x

x

x

x

x

Table 1: Treatment groups included a static and vehicle control. There were three loading
treatments: perfusion flow, high-shear oscillatory flow, and portioned high-shear oscillatory
flow. Loading occurred for one hour followed by 24 hours of incubation. There were two
incubation methods: static or perfusion.

0.075

40

40
40
0.075

40

Figure 2 - Flow profiles for loading regimes. Perfusion flow remained at a constant flow rate, while
oscillatory flow fluctuated sinusoidally. When oscillatory flow was superimposed over perfusion flow,
the net flow was equal to the rate of perfusion flow.
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The syringe pump delivered media at a rate of 0.025 mL/min (0.0006 Pa) for
perfusion flow. This rate was not high enough to be within the range considered to be
effective mechanical stimulation for bone cells (8), and was therefore considered to be
low-shear. To deliver high-shear fluid flow (mechanical stimulation), the linear actuator
was used to superimpose oscillatory flow on perfusion flow with a sinusoidal waveform
at a maximum rate of 40 mL/min, with a frequency of 1 Hz. This rate created estimated
shear stresses of ~1.0 Pa. Flow profiles for all loading regimes can be seen in Figure 2.
Oscillatory flow was applied immediately after perfusion was initiated and
continued for either 1 hour (continuous loading) or was partitioned into four intermittent,
fifteen minute bouts with fifteen minutes of rest between loadings. For static cultures,
scaffolds remained in 24-well plates. All experimentation was performed in an incubator
maintained at 37°C and 5% CO2.
Total loading time for all mechanical treatments equaled one hour.

After

treatment (loading), scaffolds were removed from the bioreactor, placed into 24-well

Gene Name

Function

Primer Sequence

Osteopontin

Osteoblast
Differentiation

F: 5'- CAGCTGGATGAACCAAGTCTGGAA -3';
R: 5'- ACTAGCTTGTCCTTGTGGCTGTGA -3'

Collagen Type I

Matrix Protein

F: 5'- TGGTTTGGAGAGAGCATGACCGAT -3';
R: 5'- TGTAGGCTACGCTGTTCTTGCAGT -3'

Vascular Endothelial
Growth Factor A

Angiogenesis

F: 5'- ACAGAAGGAGAGCAGAAGTCCCAT -3';
R: 5'- ATGTGCTGGCTTTGGTGAGGTTTG -3'

COX-2

Inflammatory/
osteogenic

F: 5'- TCAATACTGGAAGCCGAGCACCTT -3';
R: 5'- GCACTTGCATTGATGGTGGCTGTT -3'

Cyclophillin

Housekeeping

F: 5'- TCATGTGCCAGGGTGGTGACTTTA;
R: 5'- ATGCTTGCCATCCAGCCATTCAGT -3'

Beta-Actin

Housekeeping

F: 5'- ATCACTATTGGCAACGAGCGGTTC -3';
R: 5'- TCTCCTTCTGCATCCTGTCAGCAA -3'

Ubiquitin

Housekeeping

F:5'-CGTCGAGCCCAGTGTTACCACCAAGAAGG-3;
R:5'-CCCCCATCACACCCAAGAACAAGCACAAG-3'

Table 2 – Primer design and function for genes of interest in partitioned mechanical study.
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plates, covered with 2 mL of media, and statically incubated, or they remained in the
bioreactor under constant perfusion flow for the remaining incubation time. At 25 hours
after the onset of the loading treatment, RNA was isolated, and mRNA levels were
determined for osteogenic and angiogenic genes (Table 2).

Experimental Design – Experiment 2
For the second experiment, conditions were changed to amplify cellular response.
While the same treatment groups were used, flow rates were modified. The syringe
pump delivered media at a new rate of 0.075 mL/min (~0.0017 Pa) for perfusion flow.
The linear actuator superimposed oscillatory flow on perfusion flow with a sinusoidal
waveform at a new maximum rate of 120 mL/min (2.2 Pa), at a frequency of 2.2 Hz.
Twenty-five hours after the onset of loading (identical time point as experiment 1),
mRNA levels for osteogenic and angiogenic genes were quantified.

RNA Isolation, RT-PCR
Scaffolds were placed in 2 ml tubes and crushed in SV Lysis Buffer with a glass
rod. After lysis, dilution buffer was added along with 200 mM phosphate buffer to elute
the RNA. RNA was isolated from cells using the Promega SV total RNA Isolation kit
according to manufacturer’s instructions.

RNA concentration and quality was

determined using spectrophotometer (Nanodrop ND-1000 spectrophotometer, Nanodrop
Technologies, Rockland, DE) readings at 260, 230, and 280 nm. Gel electrophoresis was
used to verify RNA integrity. RNA was reverse transcribed into cDNA using a reaction
mix consisting of Superscript II reverse transcriptase (Invitrogen, Calrsbad, CA), 1x first
strand buffer (Invitrogen), 800 µM dNTPs (Promega), Rnase out recombinant
ribonuclease inhibitor (Invitrogen), 48 mM dithiothreitol (Invitrogen) and 0.5 µg
Oligo(dT)12-18 primer at 42°C for 20 minutes, 50°C for 10 minutes and 42°C for 1 hour in
the Mastercycler Gradient Thermocycler (Eppendorf, Westbury, NY). cDNA was then
used for real time PCR for the genes of interest and the housekeeping gene (Table 1).
All reactions were performed in the StepOnePlus real-time PCR system (Applied
Biosystems) under the following cycle parameters: hot start at 95°C for 15 minutes
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followed by 40 cycles of 95°C for 15 seconds, 60°C for 30 seconds and 72°C for 15
seconds. Threshold fluorescence was set to 1500 dR and the Ct value was determined for
all reactions. Ct values were used to determine the relative up or down regulation for
each gene using the relative standard curve method and normalizing to one housekeeping
gene that does not change between treatments (18).

Statistics
A two-factor (loading, incubation) analysis of variance (ANOVA) was used to
test for model effects comparing mRNA levels. If significance was attained, follow-up
post-hoc tests (students-T) were run to determine differences between pairs. JMP IN 5.1
statistical software package (SAS, Cary, NC) was used for all statistical analyses with a
significance level of 0.05.

Results – Experiment 1
Loading had no effect on gene expression for any gene of interest. Even when
one-factor ANOVAs were run within each incubation method (static vs. perfusion),
neither perfusion flow nor mechanical stimulation (single bout or partitioned bouts)
elicited changes in gene expression.

Relative Gene Expression (Fold
Change Over Vehicle)

In contrast, incubation method affected gene expression (Figure 3) with perfusion
Static
Perfusion
Mech.
Part. Mech.
P. Perfusion
P. Mech.
P. Part. Mech.

2.5
2
1.5
1
p<.0001

0.5
0
OPN

Cox-2

Col I

Figure 3 - Gene expression of OPN is down-regulated with perfusion incubation compared to
static incubation. Loading method did not alter gene expression in any gene measured.
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incubation down-regulating the gene expression of OPN by ~75% (p < 0.0001). No other
genes had significant effects.
In this experiment, shear stresses experienced by cells attached to the scaffolds
were estimated according to the following equations:
τw = Q*x
where τw = average shear stress, Q = flow rate, and
x = 8*μ/(d*(Φ*Π(d/2)2))
where μ is the viscosity of the culture medium (0.01 dyne-s/cm2), d is the diameter of the
average pore size, and Φ is the porosity.
These calculations suggested that at a high-shear oscillatory flow rate of 40
mL/min, cells would be subjected to shear stresses of ~1.0 Pa. This falls within the range
of physiological shear stresses estimated to be experienced by osteoblasts in vivo. Lowshear perfusion flow at a rate of 0.025 mL/min causes shear stresses several orders of
magnitude lower than in vivo estimations (0.0006 Pa).

Discussion
Mechanical stimulation had no effect on mRNA levels of any genes that were
tested. As the equations estimating shear stress were developed for basic flow through a
pipe, we decided to utilize a Computational Fluid Dynamics model to obtain a more
accurate estimate of shear stresses experienced by cells within our scaffolds (19).
Calculations suggested that at a flow rate of 40 mL/min, cells would only be subjected to
shear stresses of ~0.7 Pa, rather than the 2.0 Pa originally calculated. Since shear stresses
necessary to induce a response to mechanical stimulation in vivo have been estimated to
be in the range of 0.8-3.0 Pa (20) we thought it necessary to increase the shear stress
profile in future experiments. Therefore, a new rate of 120 mL/min was used, providing
shear stresses of ~2.2 Pa (19).
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Since literature has shown that perfusion flow increases many bone-related genes
(OPN, Col1, etc) at later time points (e.g. 7 and 14 days) (3,4,21,22), we hypothesized
that perfusion would increase those same genes at earlier time points (e.g. 24 hours) as
well. Rather than up-regulating gene expression, perfusion incubation actually reduced
OPN expression significantly. This was concerning as it suggested a potential reduction
in osteoblast activity. We concluded that the rate of perfusion flow utilized in our
bioreactor was not high enough to improve the oxygen and nutrient delivery necessary
for increased osteoblast activity. Thus, we chose to increase the level of perfusion flow
to better match values existing in literature.

Results – Experiment 2
Results for Experiment 2 were similar to Experiment 1. Loading had no effect on
gene expression for any gene of interest (p > 0.53). Even when one-factor ANOVAs
were run within each incubation method (static vs. perfusion), neither perfusion flow nor
mechanical stimulation (single bout or partitioned bouts) elicited changes in gene
expression.

Static

Relative Gene Expression
Normalized to Vehicle

2.5

Perfusion

2.0

Mechanical
Partitioned Mechanical

1.5

Perfusion - Perfusion

1.0

Mechanical - Perfusion
p=0.0002
Partitioned Mechanical Perfusion

0.5
0.0
OPN

Col1

COX-2

Figure 4 - OPN gene expression is down-regulated by perfusion incubation. Loading does
not alter gene expression in static or perfusion incubation.
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Here too, incubation method affected gene expression with perfusion incubation
down-regulating the gene expression of OPN (Figure 4) by ~65% (p = 0.0002). No other
genes had significant effects (Table 3).

Model Effects

Loading

Incubation

Interaction

OPN *

0.0053

0.98

0.0002

0.59

VEGF

0.12

0.81

0.014

0.62

Col1

0.086

0.53

0.56

0.82

COX-2

0.99

0.99

0.95

0.89

Bcl-2/Bax

0.4

0.89

0.074

0.56

Table 3 - p-values for all genes with two-factor ANOVA. * = significant model effect.
Only OPN was significant with perfusion flow decreasing OPN expression.

Discussion
As osteoblasts differentiate, they progress through a well-established pattern of
gene expression, resulting in the deposition of calcium throughout a collagenous matrix
(23). Alkaline phosphatase, osteopontin, and osteocalcin, each considered to be markers
of osteoblast differentiation, follow a similar pattern of expression, increasing over the
course of matrix maturation. ALP mRNA precedes OPN and OCN mRNA expression by
approximately one week, peaking at approximately 21 days of culture in differentiation
media. Collagen I expression peaks two week prior to ALP, and subsequently decreases
in expression throughout the maturation process.
When using perfusion flow in 3D osteoblast cultures, literature demonstrates an
increase in ALP, OPN, and OCN gene expression during long-term studies (7-14 days)
(3,4,21,22). We expected to see early (24-48 hours) changes in gene expression that
correlated to later time points presented in literature. As this did not occur, we concluded
that either A) our bioreactor system did not provide adequate stimulation, or B) long-term
gene expression may not predict similar patterns in early gene expression. A smaller,
higher sample size experiment was designed to explore early patterns of gene expression
in static incubation vs. perfusion incubation.
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As mechanical stimulation is recognized as a major mediator of gene expression
in osteoblasts, we hypothesized that high-shear oscillatory fluid flow (in single or
multiple bouts) would increase gene expression in osteoblasts seeded in 3D. In 2D
studies, mechanical stimulation has been shown to increase several of the genes we chose
to measure (24-26), but there remains a paucity of data studying the effects of mechanical
stimulation in 3D cultures, especially at early time points.

Neither mechanical

stimulation nor partitioned mechanical stimulation had any effects on gene expression
during static incubation or perfusion incubation. To further elucidate the effects of
mechanical stimulation in 3D, we designed another experiment that compared the effects
of high-shear oscillatory flow on osteoblasts in both 2D and 3D.
In conclusion, under the conditions described, mechanical stimulation (single or
multiple bouts) does not alter gene expression in 3D scaffolds after 24 hours of loading.
However, 24 hours of perfusion incubation reduces the expression of OPN, suggesting a
reduction in osteoblast activity.
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Introduction
Bone tissue engineering is an expanding field that involves the use of threedimensional (3D) constructs that could potentially be used as bone graft substitutes.
While autografting is still the predominant choice for bone defect repair, the increasing
popularity of synthetic bone grafts is driving the need for continued development in this
area. To maximize the success of bone tissue engineering development, it is critical that
we obtain a deeper understanding of cellular biology in an in vitro, three-dimensional
architecture. Additionally, as perfusion bioreactors have become popular for 3D cell
culture, it is necessary to understand the physical effects that fluid flow can have on cells
in three dimensions.
Mechanical stimulation is recognized as a major mediator of both osteogenic and
angiogenic activity in bone [1-6]. The adaptation of bone to mechanical loading is
attributed to mechanotransduction, which is the conversion of mechanical stimuli into
biochemical responses. In vivo, mechanical loading increases bone volume [7], bone
strength [6, 8], bone formation rate [9], and angiogenic activity [10]. Prior to osteogenic
endpoints, in vivo loading increases the gene expression of vital matrix proteins such as
osteocalcin (OCN), collagen 1 (Col 1), and alkaline phosphatase (ALP) [11, 12].
Upstream of angiogenic activity, loading has been shown to augment the expression of
vascular endothelial growth factor (VEGF) [13].
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Historically, 2D in vitro cultures have played a key role in the study of bone
mechanobiology. Subjecting bone cells to mechanical loading in 2D leads to increased
expression of osteogenic genes such as OPN and Col 1 [14-19]. Similarly, loading in 2D
also mediates angiogenic expression; osteoblast-like cells increase VEGF expression
when exposed to either fluid flow [20] or mechanically-induced strain [21-23]. These 2D
results (both osteogenic and angiogenic) parallel in vivo findings [11-13]. However, 2D
experiments are performed on flat surfaces, which do not mimic in vivo 3D architecture.
Thus, 3D in vitro models may provide more physiological environments for
mechanotransduction studies.
Cells have been shown to react differently in 2D and 3D environments [24-27].
For example, both ALP and OCN (measures of osteoblast differentiation) were upregulated in 3D cultures of human mesenchymal stem cells compared to those cultured in
2D [28, 29]. In another study, osteoblast-like cells exhibited enhanced angiogenic gene
expression when cultured in 3D compared to those cultured in 2D [30]. Considering
these results, it is clear that 2D models do not always accurately represent what will occur
in 3D conditions.
Mechanical stimulation in 3D osteoblast cultures has not been studied
extensively. However, there is literature showing that perfusion flow increases matrix
production [31-33], mineralization [31-33], and late stage osteogenic gene expression
[34, 35] in osteoblastic cells cultured on 3D scaffolds. Since the perfusion flow utilized
in the these studies resulted in shear stresses well below those experienced in vivo [36],
there remains little data on the effects of physiologically-relevant mechanical stimulation
in 3D [3, 37]. Therefore, the goal of this study was to determine if flow-induced shear
stress mediates osteogenic and angiogenic gene expression similarly in osteoblast-like
cells cultured in 2D and 3D environments.

Materials and Methods
Cell Culture
Mouse osteoblast-like cells (MC3T3-E1 subclone 4, ATCC, Manassas, VA)
between passage numbers 3 and 10 were cultured in alpha-MEM (Invitrogen, Carlsband,
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CA) with 10% FBS (Hyclone, Logan, UT) and 1% pen/strep (Cellgro, Herndon, VA).
Once cells reached ~70% confluency, they were trypsinized, re-suspended in culture
medium, and statically seeded evenly onto either 2D glass slides (~ 7,000 cells/cm2) or
3D calcium phosphate scaffolds (1,000,000 cells/scaffold) (BD Biosciences, San Jose,
CA). The scaffolds have an interconnected porosity of ~ 60% with an average pore size
of 200-400 microns. This is comparable to trabecular bone (50-90% porosity, 500-1500
micron pore size [38]), and within the range suggested to be optimal for bone
regeneration (150 – 650 microns) in porous scaffolds [39]. Samples were then incubated
for 1 hour to allow cell adhesion, and were covered with media and incubated for 24
hours before experiments began.

Figure 5 - Bioreactor setup with only the linear actuator in line. Only high-shear oscillatory
fluid flow was used. See text for more details.
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Mechanical Loading in 3D
A custom perfusion bioreactor was used to mechanically stimulate osteoblasts on
calcium phosphate scaffolds. Each bioreactor chamber consists of a top and bottom
aluminum block, between which a polycarbonate block is secured (Fig. 5). A space was
drilled out of the polycarbonate block to fit a porous calcium phosphate scaffold 5-mm in
diameter and 3.5-mm in height (BD Biosciences, Bedford, MA). A 4-mm hole was
drilled through the center of all three blocks to allow fluid flow through the scaffold.
Grooves were machined around both the hole and the space on each side of the
polycarbonate block to fit a #11 Viton O-ring (Allorings, Hampton Falls, NH). A 1/8th
inch barbed pipe connector was threaded into both the top and bottom aluminum blocks
and connected to 1/8th inch silicone tubing (Harvard Apparatus, Holliston, MA). The
silicone tubing used is permeable to both CO2 and O2, so that cells were permitted
adequate gas exchange. Tubing connected the top of the chamber to a 140 ml syringe
fluid reservoir.

In addition, tubing connected the bottom of the chamber to an

electromagnetic linear actuator (Linmot, Delavan, WI). The linear actuator imposed
oscillatory flow at a controlled shear rate 2.2 Hz. Using these bioreactor and scaffold
parameters, a computational fluid dynamics model was developed to estimate the shear
stresses experienced by the cells within these scaffolds [40]. Calculations suggest that
scaffolds subjected to a sinusoidal oscillatory flow profile at 120 ml/min will expose cells
to an average shear stress of 2.2 Pa [40].

Mechanical Loading in 2D
For loading in 2D, cell-seeded glass slides were placed in a parallel-plate flow
chamber (StreamerTM, Flexcell International Corp, Hillsborough, NC) and connected to
the same flow system. The linear actuator imposed oscillatory flow to expose cells to a
shear stress of 2.2 Pa at a rate of 2.2 Hz.

Experimental Design
There were two model treatments (2D and 3D) and two loading treatments (static
and mechanical). Each model/loading treatment combination contained 5 biological
replicates. The static treatments remained incubated at 37°C with 5% CO2 for the
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duration of the experiment. The mechanical treatments were placed in their respective
loading chambers and connected to the flow circuit. Loading occurred immediately after
the circuit was connected and continued for 1 hour, after which they were removed and
statically incubated for 23 hours. At this point, RNA was isolated, or samples were
loaded a second time for 1 hour, followed by another 23 hour static incubation, after
which RNA was isolated. Thus, 48 hour mechanical samples were loaded twice; for 1
hour at the beginning of each 24 hour period.

RNA Isolation, RT-PCR
For cells seeded on glass slides, the cells were trypsinized, pelleted, and lysed in
SV Lysis Buffer. For cell-seeded scaffolds, samples were placed in 2 ml tubes and
crushed in SV Lysis Buffer with a glass rod. After lysis, dilution buffer was added along
with 200 mM phosphate buffer to elute the RNA. RNA was isolated from cells using the
Promega SV total RNA Isolation kit according to manufacturer’s instructions. RNA
concentration and quality was determined using spectrophotometer (Nanodrop ND-1000
spectrophotometer, Nanodrop Technologies, Rockland, DE) readings at 260, 230, and
280 nm. Gel electrophoresis was used to verify RNA integrity. RNA was reverse
transcribed into cDNA using a reaction mix consisting of Superscript II reverse
transcriptase (Invitrogen, Calrsbad, CA), 1x first strand buffer (Invitrogen), 800 µM
dNTPs (Promega), Rnase out recombinant ribonuclease inhibitor (Invitrogen), 48 mM
dithiothreitol (Invitrogen) and 0.5 µg Oligo(dT)12-18 primer at 42°C for 20 minutes,
50°C for 10 minutes and 42°C for 1 hour in the Mastercycler Gradient Thermocycler
(Eppendorf, Westbury, NY). cDNA was then used for real time PCR for the genes of
interest and the housekeeping gene (Table 4).
All reactions were performed in the StepOnePlus real-time PCR system (Applied
Biosystems) under the following cycle parameters: hot start at 95°C for 15 minutes
followed by 40 cycles of 95°C for 15 seconds, 60°C for 30 seconds and 72°C for 15
seconds. Threshold fluorescence was set to 1500 dR and the Ct value was determined for
all reactions. Ct values were used to determine the relative up or down regulation for
each gene using the relative standard curve method and normalizing to one housekeeping
gene that does not change between treatments [41].
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Table 4: Primer sequences for 2D vs 3D study with high-shear oscillatory fluid flow.

Statistics
Five samples were tested for each of the 4 experimental conditions: 2D-Static,
2D-Mechanical, 3D-Static, 3D-Mechanical. A one way analysis of variance (ANOVA)
was used to compare the mRNA levels between static cultures in 2D and 3D. A one way
ANOVA was used to compare static and mechanical loading treatments within 2D and
3D cultures to determine the effects of mechanical stimulation in 2D and 3D. For
graphical representation, gene expression was normalized to the average value of 2D
Static samples. JMP IN 5.1 statistical software package (SAS, Cary, NC) was used for
all statistical analyses with a significance level of 0.05.

Results
2D vs. 3D
There were several differences in gene expression between 2D and 3D under
static culture, including OPN, Col1, FGF-2, and M-CSF (Table 5).
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At 24 hours, OPN, a marker of osteoblast differentiation, and FGF-2, an
angiogenic growth factor, were significantly (p < 0.0009) up-regulated in 3D by 22.5 and
4.1 fold, respectfully. In contrast, Col1, the most predominant bone matrix protein, and
M-CSF, a chemotactic factor for macrophages (osteoclasts), were both down-regulated (p
< 0.0132) in 3D, by 7.5 and 6.1 fold, respectively. RUNX2, COX-2, and VEGF were not
significantly different (p > 0.2839).

Table 5: Fold changes in gene expression at 24 and 48 hours in static 3D osteoblast
cultures relative to 2D cultures.

At 48 hours, there were also significant differences between 2D and 3D static
treatments. Similar to 24 hours, OPN and FGF-2 were up-regulated in 3D at 19.1 and
10.3 fold (p < 0.0009). Col1 was down-regulated in 3D at 4.0 fold (p = 0.0211) (Table
5). There was no significant change in M-CSF, RUNX2, COX-2, or VEGF between 2D
and 3D (p > 0.3034).

Static vs. Mechanical
No differences were seen with mechanical stimulation at 24 hours in either 2D (p
> 0.3514) or 3D (p > 0.5419) when compared to static conditions. However, mechanical
stimulation did have significant effects on gene expression at 48 hours, but the changes
were not consistent between 2D and 3D models. OPN was up-regulated significantly (p
= 0.0302) in 2D by ~ 50% (Fig. 6). In contrast, culture in 3D down-regulated OPN gene
expression (p = 0.0099) by ~ 50% (Fig. 6).
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Figure 6: OPN gene expression at 48 hours in MC3T3 pre-osteoblasts after 1 hour of oscillatory fluid
flow (per day) followed by 23 hours of static culture. Samples were loaded 2 times – once at the
beginning of each 24 hour period. Represented as means (n=5) with standard error bars.

FGF-2, a potent angiogenic factor, was not affected (p = 0.6165) by mechanical
loading in 2D cultures (Fig. 7), but was reduced (p = 0.0691) after mechanical
stimulation in 3D.

With COX-2, the limiting enzyme in the production of PGE2,

mechanical loading in 2D had no effect (p > 0.8519). However, in 3D, COX-2 gene
expression increased (p = 0.0416) when exposed to mechanical stimulation (Fig. 8). Col
1, RUNX-2, M-CSF, and VEGF-A were not affected by mechanical stimulation in 2D (p
> 0.3302) or 3D (p > 0.2847) at 48 hours (data not shown).

Figure 7: FGF-2 is down-regulated at 48 hours in 3D, but not 2D when osteoblasts are exposed to 1 hour of fluid
flow (per day) followed by 23 hours of static culture. Represented as means (n = 5) with standard error bars.
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Figure 8: COX-2 is up-regulated significantly at 48 hours in 3D, but not 2D when osteoblasts are exposed to 1
hour of oscillatory fluid flow each day. Represented as means (n = 5) with standard error bars.

Discussion
The purpose of this study was to determine whether osteoblastic cells respond
similarly to fluid-induced shear when cultured on 3D scaffolds and 2D glass slides. We
found differential expression of several genes when comparing 3D and 2D cultures
(Table 5). Moreover, when comparing effects of mechanical stimulation, 3D cultures
responded differently than 2D cultures. These results support future work to identify the
signaling pathways responsible for the different responses of osteoblast-like cells to
mechanical stimulation on different architectures.
Our results showed different levels of gene expression between 2D and 3D
osteoblast cultures under static conditions. At 24 and 48 hours, both OPN and FGF-2
were up-regulated in 3D, while collagen-1 was down-regulated in 3D (Table 5). One
possibility for these differences in gene expression is that, under static incubation, 3D
scaffolds experience a decrease in nutrient and oxygen delivery to the scaffold center.
These conditions are consistent with those experienced under hypoxia, and are common
in 3D constructs [42, 43]. It is know that OPN gene expression and FGF-2 protein
production are increased under hypoxic conditions [44-47]. Interestingly, ERK1/2 is also
activated under hypoxic conditions [48], and has been identified in the signaling
pathways for both OPN and FGF-2. This important link suggests that when cultured
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statically in 3D, osteoblasts may experience a hypoxia-driven increase in both OPN and
FGF-2, possibly mediated by the ERK1/2 pathway. Furthermore, as Col 1 is decreased in
MSC’s under hypoxia [44], a decrease in Col 1 gene expression in the present study
further suggests hypoxic conditions in static 3D cultures.

Future experimentation

measuring ERK1/2 or hypoxic activity (e.g. HIF-alpha expression) is necessary to
determine whether hypoxia indeed plays a role in 3D osteoblast culture.
Previous studies suggest that OPN is up-regulated in pre-osteoblasts when
exposed to mechanical stimulation; oscillatory flow up-regulated OPN by ~4 fold after 2
hours of stimulation, and by ~2.5 fold after 24 hours of stimulation in MC3T3 cells [15,
16]. In the present study, oscillatory flow up-regulated OPN in 2D cultures at both 24
and 48 hours (Fig. 6). However, significance was only achieved at 48 hours (2-fold, p =
0.0302). A larger sample size may establish significance at 24 hours, as OPN was upregulated by 3-fold (p = 0.3514) when cells were exposed to mechanical stimulation.
Contrasting 2D results, OPN was down-regulated (p = 0.0099) by oscillatory flow in 3D
culture (Fig. 6) at 48 hours. Similarly, fluid flow also decreased FGF-2 (p = 0.0691), a
potent angiogenic factor at 48 hours (Fig. 7). Like OPN, this result was unexpected as
FGF-2 has been shown to be increased in osteoblasts after exposure to mechanical
stimulation in 2D [23, 49, 50].
The different responses to mechanical loading in 2D and 3D cultures may be
explained by hypoxic conditions induced by 3D culture. If OPN and FGF-2 are upregulated in static 3D cultures because of a lack of oxygen delivery, fluid flow could
counter this effect by delivering oxygen and down-regulating genes previously increased
by the hypoxic state.

If true, nutrient and oxygen delivery may supersede

mechanotransduction in affecting OPN and FGF-2 gene expression in 3D. This suggests
that different mechanisms drive cellular responses to fluid flow in 2D and 3D cultures.
One limitation of this study is the difference in substrates between 2D and 3D
treatments. With glass as the substrate in our 2D model and calcium phosphate in our 3D
model, it is possible that some of the changes in gene expression are due to differences in
materials. In a 2D study comparing the effects of calcium phosphate-coated slides and
plain glass slides, there were several changes in gene expression that were attributed to
substrate. Bone sialoprotein, OPN, and RUNX2 were all up-regulated in human bone
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marrow stromal cells when cultured on calcium phosphate (~2 fold, ~2 fold, ~1.5 fold
respectively) compared to cells cultured on glass slides [51]. Thus, some of the changes
in gene expression seen in our study may be due to substrate differences. However, we
used the same calcium phosphate as the above study in our 3D scaffolds (Skelite™ - BD
Biosciences). Since the fold changes seen in OPN in the present study (> 19 fold) were
much greater than those seen in the 2D study above (~ 2 fold), we feel that the upregulation in gene expression can be attributed to differences in architecture rather than
substrate material. The increases in OPN levels of 23- and 19-fold at 24 and 48 hours
(static comparison) in the present study are much greater than the 2-fold increase seen on
calcium phosphate-coated slides in 2D [51]. Moreover, calcium phosphate did not elicit
changes in Col 1 mRNA levels on 2D glass slides, whereas we saw significant decreases
of 7- and 3.5- fold at 24 and 48 hours, respectively. Thus, the differences in gene
expression in our study may be more strongly influenced by architecture than substrate.
Whether or not hypoxic conditions drive the distinct responses to substrate and
fluid flow, it is clear that differences do exist between 2D and 3D cultures, suggesting
that data collected in 2D studies may not be relevant to more complex 3D environments.
Furthermore, when exposed to fluid flow in 3D, osteoblasts respond differently than
when cultured in 2D. These results highlight the importance of future experimentation on
mechanotransduction in 3D culture. Future research controlling the parameters of a 3D
grafting structure, and studying in vitro cultures under dynamic conditions will provide
critical information to define fundamental biochemical and biomechanical responses of
bone cells.
The goal of bone tissue engineering is to produce 3D bone-like tissue in vitro that
will respond functionally when implanted into the body. A major limitation is poor
cellular viability in the center of 3D scaffolds. Our model may increase cellular viability
in the center of 3D scaffolds through the reduction of hypoxic-like conditions. This
would not only advance the quality of tissue-engineered bone, but should decrease
culture times.

Thus, utilizing fluid flow in a 3D bioreactor to stimulate osteoblast

cultures holds promise for bone tissue engineering applications.
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CHAPTER FOUR
Perfusion Flow vs. Static Culture
Perfusion Flow Mediates Hypoxia-Specific Gene Expression in MC3T3 Osteoblastic
Cells
Matthew J. Barron, B.S., Jeremy Goldman, Ph.D., Seth W. Donahue, Ph.D.

Introduction
Bone transplants are often necessary for spinal fusion, fracture healing, and
defects resulting from trauma or disease (1-3). While autografts remain the best available
option for bone grafting, the pain and morbidity associated with second surgeries
combined with the limited availability of autograft sources drive the development of
alternative grafting materials (1-3). Three-dimensional (3D) bone tissue engineering is
promising to be an effective therapy for skeletal defect repair, with success defined by
host acceptance, mechanical stability, and host tissue integration (1-3). 3D bone tissue
engineering combines porous synthetic scaffolds, which allow tissue in-growth
(osteoconductive), with growth factors to induce bone growth (osteoinductive) and/or
osteoblasts (or mesenchymal stem cells) to produce bone (osteogenic).

While this

approach has seen success, a common limitation is the maintenance of cellular viability
within the center of 3D constructs (6,7,13).
The delivery of oxygen and nutrients and the removal of waste are essential for
cellular survival. Because of oxygen’s poor diffusion capacity, oxygen transport largely
governs the production of 3D tissue cultures in vitro (4,5). Perfusion bioreactors mitigate
hypoxic (oxygen-depleted) conditions, as they provide a means of oxygen delivery to the
center of 3D cell-seeded scaffolds (4). By constantly perfusing culture media through
porous constructs, bioreactor systems have increased cellular infiltration and viability
within 3D scaffolds by increasing the level of oxygen transport (4,6-10). This leads to
up-regulation in gene expression (6,8,11), increases in protein production (7,10,12-15),
and enhanced calcium deposition (7,13,16-18) in osteoblast-seeded scaffolds.
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It is clear that hypoxia must be given consideration in tissue engineering
applications. Given that perfusion bioreactors increase oxygen transport to 3D scaffolds
(4), and that hypoxia restricts osteoblast differentiaton (19-22), it is reasonable to
hypothesize that some of the benefit associated with the use of perfusion flow (6-8,1018) may be attributed to the reduction of hypoxia in 3D culture. As most studies have
focused on the ability of 3D perfusion systems to produce higher quality bone, few
studies have sought to elucidate the molecular mechanisms behind the success of
perfusion bioreactors. Thus, the goal of this study was to determine if hypoxia-specific
gene expression in osteoblast-like cells cultured in a 3D scaffolds is affected by perfusion
flow.

We hypothesized that perfusion flow would reduce hypoxia-specific gene

expression and increase cellular infiltration in osteoblast-seeded 3D scaffolds.

Materials and Methods
Cell Culture
Mouse osteoblast-like cells (MC3T3-E1 subclone 4, ATCC, Manassas, VA)
between passage numbers 3 and 10 were cultured in alpha-MEM (Invitrogen, Carlsband,
CA) with 10% FBS (Hyclone, Logan, UT) and 1% pen/strep (Cellgro, Herndon, VA).
Once cells reached ~70% confluency, they were trypsinized, re-suspended in culture
medium, and statically seeded on 3D calcium phosphate scaffolds (1,000,000
cells/scaffold) (BD Biosciences, San Jose, CA). The scaffolds have an interconnected
porosity of ~ 60% with an average pore size of 200-400 microns. This is comparable to
trabecular bone (50-90% porosity, 500-1500 micron pore size (23)), and within the range
suggested to be optimal for bone regeneration (150 – 650 microns) in porous scaffolds
(24). Samples were then incubated for 1 hour to allow cell adhesion, and were covered
with media and incubated for 24 hours before experiments began.

Perfusion Flow Bioreactor
A custom perfusion bioreactor was used to deliver culture media to osteoblasts on
calcium phosphate scaffolds. Each bioreactor chamber consists of a top and bottom
aluminum block, between which a polycarbonate block is secured (Figure 9). A 6-mm
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hole was drilled out of the polycarbonate block to fit a porous calcium phosphate scaffold
5-mm in diameter and 3.5-mm in height (BD Biosciences, Bedford, MA). A 4-mm hole
was drilled through the center of all three blocks to allow fluid flow through the scaffold.
Grooves were machined around both the hole and the space on each side of the
polycarbonate block to fit a #11 Viton O-ring (Allorings, Hampton Falls, NH). A 1/8th
inch barbed pipe connector was threaded into both the top and bottom aluminum blocks
and connected to 1/8th inch silicone tubing (Harvard Apparatus, Holliston, MA). The
silicone tubing is permeable to CO2 and O2, permitting adequate gas exchange. Tubing
connected the top of the chamber to a 140 ml syringe fluid reservoir, and the bottom of
the chamber to syringe pump (Harvard Apparatus). The pump delivered media at a rate
of 0.075 ml/min (0.00017 Pa), with media being replaced each day.
Experimental Design – Gene Expression
Cell seeded scaffolds were cultured statically in an incubator or with perfusion
flow in the bioreactor. The static samples remained incubated at 37°C with 5% CO2 for
the duration of the experiment. The perfusion samples were cultured in the bioreactor
chambers. Perfusion flow was initiated immediately after the samples were placed in the
chamber and continued for the remainder of the experiment. Samples were exposed to
flow for 24 or 48 hours (n=5 per time point). Static samples were also incubated for 24
or 48 hours (n=5 per time point). After 24 or 48 hours of culture, the samples were
removed from static or perfusion incubation and RNA was isolated.

RNA Isolation and RT-PCR
After culture, cell-seeded scaffolds were placed in 2 ml tubes and crushed in SV
Lysis Buffer with a glass rod. After lysis, dilution buffer was added along with 200 mM
phosphate buffer to elute the RNA. RNA was isolated from cells using the Promega SV
total RNA Isolation kit according to manufacturer’s instructions. RNA concentration and
quality was determined using spectrophotometer (Nanodrop ND-1000 spectrophotometer,
Nanodrop Technologies, Rockland, DE) readings at 260, 230, and 280 nm. Gel
electrophoresis was used to verify RNA integrity. RNA was reverse transcribed into
cDNA using a reaction mix consisting of Superscript II reverse transcriptase (Invitrogen,
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Calrsbad, CA), 1x first strand buffer (Invitrogen), 800 µM dNTPs (Promega), Rnase out
recombinant ribonuclease inhibitor (Invitrogen), 48 mM dithiothreitol (Invitrogen) and
0.5 µg Oligo(dT)12-18 primer at 42°C for 20 minutes, 50°C for 10 minutes and 42°C for 1
hour in the Mastercycler Gradient Thermocycler (Eppendorf, Westbury, NY). cDNA was
then used for real time PCR for the genes of interest and the housekeeping gene (Table
6).

Figure 9 - Bioreactor setup for perfusion incubation. The linear actuator was not used in this
study. The syringe pump delivered fluid at a rate of 0.075 mL/min. See text for more detail.
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Gene Name

Function

Primer Sequence

Osteocalcin

Osteoblast
Differentiation

F: 5'- GAGTCTGACAAAGCCTTCATGTCC -3';
R: 5'- TGATAGCTCGTCACAAGCAGGGTTA -3'

Osteopontin

Osteoblast
Differentiation

F: 5'- CAGCTGGATGAACCAAGTCTGGAA -3';
R: 5'- ACTAGCTTGTCCTTGTGGCTGTGA -3'

Alkaline Phosphatase

Osteoblast
Differentiation

F: 5'-GCCCTCTCCAAGACATATA-3';
R: 5'-CCATGATCACGTCGATATCC-3'

RUNX-2

Osteoblast
Differentiation

F: 5'- AGAGTCAGATTACAGATCCCAGGC -3';
R: 5'- GTCAGAGGTGGCAGTGTCATCAT -3'

Collagen Type I

Matrix Protein

F: 5'- TGGTTTGGAGAGAGCATGACCGAT -3';
R: 5'- TGTAGGCTACGCTGTTCTTGCAGT -3'

Vascular Endothelial
Growth Factor A

Angiogenesis

F: 5'- ACAGAAGGAGAGCAGAAGTCCCAT -3';
R: 5'- ATGTGCTGGCTTTGGTGAGGTTTG -3'

Basic Fibroblast
Growth Factor 2

Angiogenesis

F: 5'- AGCGGCTCTACTGCAAGAAC -3';
R: 5'- TGGCACACACTCCCTTGATA -3'

Macrophage Colony
Stimulating Factor

Angiogenesis

F: 5'- ATGGACACCTGAAGGTCCTG -3';
R: 5'- GCTGGAGAGGAGTCTCATGG -3'

COX-2

Inflammatory/
osteogenic

F: 5'- TCAATACTGGAAGCCGAGCACCTT -3';
R: 5'- GCACTTGCATTGATGGTGGCTGTT -3'

HIF-1α

Hypoxia

F: 5'- AAACTTCTGGATGCCGGTGGTCTA -3'
R: 5'- TCT CAC TGG GCC ATT TCT GTG TGT -3'

GBE-1

Hypoxia

F: 5'- GCAGGTATAAGAAGTTTAGCCAGG -3'
R: 5'- GAGAAAATGGATTCCAACCACTGAA -3'

MIF

Hypoxia

Cyclophillin

Housekeeping

F: 5'- CGCACAGTACATCGCAGTG-3'
R: 5'- CAG CGG TGC AGG TAA GTG-3'
F: 5'- TCATGTGCCAGGGTGGTGACTTTA;
R: 5'- ATGCTTGCCATCCAGCCATTCAGT -3'

Beta-Actin

Housekeeping

F: 5'- ATCACTATTGGCAACGAGCGGTTC -3';
R: 5'- TCTCCTTCTGCATCCTGTCAGCAA -3'

Ubiquitin

Housekeeping

F: 5'- CGTCGAGCCCAGTGTTACCACCAAGAAGG -3;
R: 5'- CCCCCATCACACCCAAGAACAAGCACAAG -3'

Table 6 - Primer sequences and roles for genes measure in static vs. perfusion study.

All reactions were performed in the StepOnePlus real-time PCR system (Applied
Biosystems) under the following cycle parameters: hot start at 95°C for 15 minutes
followed by 40 cycles of 95°C for 15 seconds, 60°C for 30 seconds and 72°C for 15
seconds. Threshold fluorescence was set to 1500 dR and the Ct value was determined for
all reactions. Ct values were used to determine the relative up or down regulation for
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each gene using the relative standard curve method and normalizing to one housekeeping
gene that does not change between treatments (25).
Experimental Design – Long-term Cellular Survival
The cell-seeded scaffolds that received static treatment remained incubated at
37°C with 5% CO2 for the duration of the experiment.

Cell-seeded scaffolds that

received perfusion treatments were placed into bioreactor chambers. Perfusion flow was
initiated immediately after the circuit was connected and continued for 14 days.
Following 14 days of culture, samples were removed from static or perfusion incubation
and were fixed in 10% buffered formalin for histological processing.

Cell Number, Surface Area Coverage, and Cell/Matrix Area Coverage
Following fixation, 14-day samples were placed in cassettes, covered in OCT
freeze medium, and placed under vacuum for 48 hours to remove air bubbles. Samples
were then removed, flash frozen, and sectioned on a soft tissue microtome (Microm
International, Waldorf

1

8

7

2

9

6

3

4

5

Figure 10 - Sections were removed from the middle of the scaffold parallel to the direction of
flow. Nine sample regions from each section were used to quantify cell number, surface area
coverage, and cell/matrix area coverage. Regions 1-8 are combined and are referred to as the
scaffold perimeter. Region 9 is referred to as the scaffold center.

Germany) at a thickness of 10 microns. Sections were taken from mid-way through the
scaffold running parallel to the direction of perfusion flow (Figure 10). Samples were
then decalcified in 0.5% EDTA, stained with hematoxylin and eosin, and images were
captured for the entire section from each sample at 100x total magnification. Nine
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images were taken in total, three from the upper, middle, and lower thirds of each section
(Figure 10). For cell number, surface area coverage and cell/matrix area coverage,
measurements were taken from the scaffold perimeter (regions 1-8 combined) and the
scaffold center (region 9).
Average cell number was determined by counting the total cell number in each
region within a section. For the scaffold perimeter, cell number was calculated from each
of the 8 regions and averaged so comparison could be made against the scaffold center
(region 9 – Figure 10).
Surface area coverage (represented by % total perimeter) was calculated by
measuring the ratio of cell coverage around the surface area of scaffold pores to the total
surface area of scaffold pores (including outer surface) using Bioquant (Bioquant Osteo,
Nashville, TN) software. Since surface area coverage was calculated as a percentage of
total coverage area, so averaging all 8 regions was not necessary to compare with the
scaffold center (region 9 – Figure 10).
Cell/matrix area coverage (represented as % pore space) was established by
measuring the ratio of cell and matrix area within pore spaces to total pore space using a
standard threshold value in Bioquant (Figure 11). Since cell/matrix area coverage was
calculated as a percentage of total coverage area, so averaging all 8 regions was not
necessary to compare with the scaffold center (region 9 – Figure 10).

Figure 11 - To determine cellular infiltration, a ratio was calculated between A) area
of cell/matrix coverage (thresholded red) and B) total area of pore spaces (thresholded
red). The area in red was used for measurement and was determined by setting a
threshold value in Bioquant.
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Statistics
Three (cell number and infiltration) or five (gene expression) samples were tested
for each of the 2 experimental conditions: Static and Perfusion. For cell number, surface
area coverage and cell/matrix area coverage, measurements were taken from the scaffold
perimeter (regions 1-8 combined) and the scaffold center (region 9). A one way analysis
of variance (ANOVA) was used to compare mRNA levels (gene exression), average cell
number, surface area coverage, and cell/matrix area coverage between static and
perfusion cultures for both the scaffold perimeter (regions 1-8) and the scaffold center
(region 9). JMP IN 5.1 statistical software package (SAS, Cary, NC) was used for all
statistical analyses with a significance level of 0.05.

Results
Gene Expression
After 24 hours of flow, OPN (a marker of both bone development and the
inflammatory response) was down-regulated (p = 0.03) by 10%, as was VEGF (a major
angiogenic growth factor) by 48% (p = 0.02). In contrast, COX-2, another marker of
both bone development and the inflammatory response, was up-regulated (p = 0.02) by
perfusion flow by 67% (Table 7).
After 48 hours of perfusion flow, while the same trend existed for OPN, VEGF,
and COX-2 as compared to 24 hours, the responses were not statistically significant
(p>0.20) However, HIF-1α, the major transcription factor driving the hypoxic response,
was down-regulated (0.02) by 55% (Table 7).
24 hour

Gene

change

p-value

48 hour
change

p-value

OPN

↓10%

0.03

-

-

COX-2

↑67%

0.02

-

-

VEGF

↓48%

0.02

-

-

-

-

↓45%

0.02

HIF-1

α

Table 7 - Changes in osteoblast gene expression when exposed to perfusion
flow - hypoxia-related genes are down-regulated.
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Runx-2, Col1, M-CSF, bFGF, and GBE-1 were not significantly different
between Perfusion and Static treatments at either time point (p > 0.20).

Cell Number, Surface Area Coverage, and Cell/Matrix Area Coverage
Perfusion flow increased cell number by 1.5-fold (p = 0.04) around the scaffold
perimeter (Figure 12).

Perfusion also increased cell number in the scaffold center,

although by a bigger margin of nearly 5-fold (p = 0.04), suggesting that perfusion flow

Average Osteoblast
Number Per Region

has an amplified effect in areas of poor static diffusion (Figure 12).

1000
900
800
700
600
500
400
300
200
100
0

p = 0.04

Static
Perfusion

p = 0.04

Scaffold Perimeter

Scaffold Center

Figure 12 - Perfusion flow increases cell number after 14 days of culture.

Surface area coverage was not affected by perfusion flow around the scaffold
perimeter (p = 0.25) or in the scaffold center (p = 0.56).
Cell/matrix area coverage was only increased by perfusion flow in the scaffold
center (10-fold), further supporting the hypothesis that the scaffolds’ centers are more
sensitive to perfusion flow that the outer perimeter (Figure 13).
consistent with both literature and our hypothesis.
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These results are

p = 0.02

Cell/Matrix Area
Coverage (% area
coverage)

14
12
10

Static
Perfusion

p = 0.97

8
6
4
2
0

Scaffold Perimeter

Scaffold Center

Figure 13 – Perfusion flow increases cell/matrix area coverage in the center of 3D
scaffolds after 14 days of culture

Discussion
The goal of bone tissue engineering is to produce a 3D construct with high
cellular viability and quality tissue structure. It is clear that hypoxia plays a role in
limiting successful in vitro culture of large 3D structures. Previous research has shown
that perfusion bioreactors produce higher-quality bone tissue in vitro, and reduce hypoxia
by delivering oxygen to the center of 3D scaffolds (4,7,13). We found that cell number
and cellular infiltration are both increased through the use of a perfusion bioreactor. We
also found that osteoblasts down-regulated gene expression of VEGF, HIF-1α, and OPN
when exposed to perfusion flow, suggesting perfusion flow rescues osteoblasts within 3D
structures from hypoxic-like conditions.
Hypoxia elicits a well-documented response from mesenchymal stem cells and
osteoblasts. Upon exposure to reduced oxygen tension, MSC’s and osteoblasts upregulate the exression of vascular endothelial growth factor (VEGF) and basic-fibroblast
growth factor (bFGF),

both important angiogenic genes (19,26).

OPN, which is

involved in the inflammatory response as well as bone development, is also up-regulated
under hypoxic conditions (19,27). Since we have shown that perfusion flow decreases
several of the genes that become activated during hypoxia, it is reasonable to hypothesize
that perfusion bioreactors mitigate hypoxic conditions by providing adequate oxygen
delivery.
OPN is commonly used as a benchmark endpoint in long-term 3D osteoblast
studies. Most 3D bioreactor studies (7,8,13) demonstrate that OPN is up-regulated with
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perfusion flow. In contrast, we showed that OPN is down-regulated with perfusion flow
(24-hour time point). Because the expression of several genes were diminished in the
perfusion treatment, we initially thought that total cellular activity may have been
reduced under perfusion. However, subsequent long-term experiments refuted this, as
relative cell number and cellular infiltration were both increased in perfusion flow
samples. Additionally, ongoing work in our lab shows that bone specific gene expression
(ALP, OCN) is indeed up-regulated at later time points (7 days) in 3D scaffolds exposed
to perfusion flow, while VEGF (major regulator of hypoxia) remains down-regulated
(OPN gene expression was not significantly different). This suggests that OPN may play
a dual role in 3D tissue engineering. Indeed, it is known that OPN not only contributes to
the preparation of bone matrix deposition, but also has a major role in the inflammatory
response and hypoxia. Thus, when considering the present results, it is possible that early
gene responses are driven by oxygen delivery and later gene responses are driven by
matrix modeling responses, suggesting that different mechanisms can drive OPN gene
expression in 3D cultures.
Mechanical stimulation has been shown to increase bone production in vivo as
well as osteoblast activity in vitro. Here, we believe that the increase in infiltration and
coverage are not due to mechanical stimulation, but rather to the increase in oxygen and
nutrient delivery as well as the removal of waste. Supporting evidence implies that mass
transport can mediate osteoblast activity (28), and that the shear stresses experienced by
osteoblasts in the present study only reached 0.00017 Pa, which is several orders of
magnitude lower than those required for cellular response to mechanical stimulation (29).
Furthermore, previous research in our lab showed that mechanical stimulation (fluidinduced shear stress – 2.2 Pa) did not affect the gene expression of VEGF expression
(30).
The goal of this study was to link the effects of perfusion flow on early-response
gene expression to long-term cellular survival and infiltration within 3D tissue
engineering scaffolds. Our bioreactor system increased relative cell number as well as
cellular infiltration in 3D scaffolds. Furthermore, gene expression results suggest that
perfusion flow reduces hypoxic-like conditions in our system. As hypoxia contributes to
the control of bone tissue structure, understanding the molecular mechanisms behind
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hypoxic gene expression has important indications for successful bone tissue engineering.
Thus, the consideration of hypoxia in 3D perfusion bioreactors will advance our progress
in bone tissue engineering.
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CHAPTER FIVE
2D Co-cultures
Introduction
The importance of blood vessels to bone development and fracture repair has been
known for centuries (1,2). Proper vascularization is critical for bone formation, bone
growth, and fracture healing (1-4),(5), providing bone tissue with oxygen, nutrients, and
growth factors, as well as the removing waste products. In addition to bone growth and
repair, vascularization is vital during implant assimilation (6-9). As tissue-engineering
bone is emerging as a potential source of tissue implants, vascularization must be
considered.
One of the major limitations of tissue-engineered bone is that once implanted in
vivo, significant amounts of time are required for host vasculature to infiltrate the
scaffold. Current methods rely on this in-growth of vasculature from host tissue (6,8),
which can lead to poor vascular in-growth (6). To address this, research has been
focused on the formation of a vascular network within tissue-engineered bone (6,8-11).
This can be accomplished by co-culturing bone cells and endothelial cells, which are
important components of the vasculature.
Co-culturing bone cells and endothelial cells has shown some success (6-12),
with the formation of vascular-like networks in vitro (8-10), as well as the up-regulation
of bone-specific alkaline phosphatase (7,10,13,14). Literature also reports that endothelial
cells can enhance the proliferation and differentiation of bone marrow-derived fibroblasts
(6).
As previous research suggests the potential benefits of co-culturing osteoblasts
and endothelial cells, we attempted to determine an appropriate co-culturing ratio to
utilize in three-dimensional (3D) cultures. We hypothesized that co-culturing endothelial
cells at a low percentage (with osteoblasts), would increase osteoblast proliferation as
well as osteoblast-specific gene expression.
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Materials and Methods
Cell Culture
Mouse osteoblast-like cells (MC3T3-E1 subclone 4, ATCC, Manassas, VA) were
cultured in alpha-MEM (Invitrogen, Carlsband, CA) with 10% FBS (Hyclone, Logan,
UT) and 1% pen/strep (Cellgro, Herndon, VA). Mouse microvascular endothelial cells
(EC) (EOMA, ATCC, Manassas, VA) were cultured in dulbeccos-MEM (Invitrogen,
Carlsband, CA) with 10% FBS (Hyclone, Logan, UT) and 1% pen/strep (Cellgro,
Herndon, VA).

Once cells reached ~70% confluency, they were trypsinized, re-

suspended in culture medium, and statically seeded into 6-well culture plates. Samples
were then incubated for 24 hours before experimentation.

During experimentation,

osteoblast differentiation media was used for all experimental treatments (control samples
were not differentiated) by adding 10 mM beta-glycerol phosphate and 50 mg/mL
ascorbic acid to alpha-MEM with 10% FBS and 1% pen/strep. 24-well culture dishes
were seeded at a density of 30,000 cells (MC3T3 and EOMA combined) per well with
the following four endothelial cell percentages: 25%, 10%, 5%, 0%. A control treatment
was also included, which consisted of osteoblasts alone cultured with non-differentiation
culture media. Following ten days of static culture, samples were processed to determine
either total cell population (n=3) or endothelial cell coverage (n=3).

Cell Population
After ten days of culture, samples were trypsinized and re-suspended in culture
medium.

10 µl of the cell suspension was added to 10 µl of trypan blue, and a

haemocytometer was utilized to determine cell number. Standard calculations were uses
to determine total cell number for each sample.

Endothelial cell coverage
Following ten days of culture, samples were washed with PBS, biotin-conjugated
antibody (1:250 anti-mouse CD31 – Endothelial Cell specific) was added, and samples
were incubated for 1 hour. Samples were again washed and the secondary antibody
(1:500, Alexa Fluor 755) was added and samples were incubated for 45 minutes. Three
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images were captured from each sample (covering ~50% of the section) from each
sample at 100x total magnification using both brightfield and fluorescent microscopy.
The total cell area was calculated by outlining the entire cell area (made easier as plates
were over-confluent) in Bioquant. Endothelial cell area was also calculated by outlining
the “nodes” of endothelial cells (Figure 16) in Bioquant. Endothelial cell coverage was
calculated by dividing the area of endothelial cell coverage by the total area of cell
coverage.

Gene Expression
Osteoblasts and endothelial cells were co-cultured at 2% endothelial cells to
determine whether co-cultures affect osteoblast-specific gene expression. Following 14
days of static culture, RNA was isolated from samples using the Promega SV total RNA
Isolation kit according to manufacturer’s instructions. RNA concentration and quality
was determined using spectrophotometer (Nanodrop ND-1000 spectrophotometer,
Nanodrop Technologies, Rockland, DE) readings at 260, 230, and 280 nm. Gel
electrophoresis was used to verify RNA integrity. RNA was reverse transcribed into
cDNA using a reaction mix consisting of Superscript II reverse transcriptase (Invitrogen,
Calrsbad, CA), 1x first strand buffer (Invitrogen), 800 µM dNTPs (Promega), Rnase out
recombinant ribonuclease inhibitor (Invitrogen), 48 mM dithiothreitol (Invitrogen) and
0.5 µg Oligo(dT)12-18 primer at 42°C for 20 minutes, 50°C for 10 minutes and 42°C for
1 hour in the Mastercycler Gradient Thermocycler (Eppendorf, Westbury, NY). cDNA
was then used for real time PCR for alkaline phosphatase (ALP), osteocalcin (OCN), and
a housekeeping gene.

Statistics
A one-factor ANOVA was used to compare total cell count (n=6) and mRNA
levels (n=3) of osteoblast-specific genes. JMP IN 5.1 statistical software package (SAS,
Cary, NC) was used for all statistical analyses
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Results
Cell Population
Following 10 days of culture, osteoblasts alone (0% endothelial cells) cultured in
differentiation media increased from an initial 30,000 cells to a final cell number of
136,000. Adding 5% endothelial cells up-regulated final cell number by 85% over
osteoblasts alone (p = 0.001). Adding 10% endothelial cells up-regulated the final cell
number by 135% over osteoblasts alone (p = < 0.0001). Adding 25% endothelial cells
increased final cell number by 90% (p = 0.0006). A summary of the percentage study

Total Cell Count

can be seen in Figure 14.

400000
350000
300000
250000
200000
150000
100000
50000
0

Initial Seeding
10-day Culture

Control 0 percent 5 percent 10 percent 25 percent
Percentage of Endothelial Cells
Figure 14 - Increasing the ratio of endothelial cells increases the final total cell count in
osteoblast/endothelial cell co-cultures.

Endothelial Cell Coverage
The proliferation rate of endothelial cells was much higher than that of
osteoblasts. This is evidenced by an increase in the level of endothelial cell coverage
over the course of 10 days. For example, at an initial seeding ratio of 25% endothelial
cells, 10 days of culture produced an endothelial cell coverage area of 80% (Figure 15).
This suggests that the increase in cell number seen with increasing ratios of endothelial
cells (Figure 14) can most likely be attributed to the proliferation of endothelial cells
rather than osteoblasts. This is evident in images taken from 25% endothelial cell co-
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cultures, where osteoblasts appear to have overwhelmed the surface area of the plate

% Final Coverage Area

(Figure 16).

100
80
60

Initial Seeding
10-day Culture
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0
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10 percent
25 percent
Percentage of Initial EC Seeding

Figure 15 - Increasing the ratio of endothelial cells causes endothelial cells to overwhelm the total cell
area.

Qualitatively, it was observed that at 5% co-culture, endothelial cells tended to
form “nodes” of cells rather than a network of individual or small groups of cells. As the
ratio of endothelial cells increased, it appeared that network formation between “nodes”
was more apparent (Figure 16).

A – Brightfield

A – CD31

B – Brightfield

B – CD31

Figure 16 – A) At low ratios (5%), endothelial cells tend to form "nodes" rather than networks of
individual cells. B) At higher ratios (25%), endothelial cells tend to overwhelm the cell area after 10
days of culture, but tend to form a netork between groups of cells. CD31 is only expressed by
endothelial cells. 100x magnification.
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Gene Expression
Alkaline phosphatase (ALP) mRNA levels were up-regulated (p < 0.0001) by
~130% in co-cultures after 14 days of two-dimensional culture (Figure 17). This is
consistent with results seen in literature (7,10,13,14). In contrast, osteocalcin (OCN)

Relative Gene Expression
(Normalized to 7-day OB)

mRNA levels were down-regulated (p = 0.007) by ~63% (Figure 17).
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Figure 17 - ALP is up-regulated and OCN is down-regulated in osteoblasts co-cultured with 2%
endothelial cells.

Discussion
This co-culture model included cell lines that have not been studied extensively,
making it necessary to characterize an appropriate co-culture percentage before designing
major studies. Co-cultures have been shown to not only increase the proliferation of
osteoblasts, but also to increase the level of bone-specific ALP (7,10,13,14). Thus, the
goals of this study were to determine the effects that varying ratios of endothelial cells to
osteoblasts has on the proliferation and bone-specific gene expression of osteoblasts.
Cell number results suggested that higher ratios of endothelial cells cause an
increase in overall cell number. However, it is clear from cell coverage results that these
endothelial cells proliferate much more quickly than the osteoblasts. When co-cultured at
25%, endothelial cells rapidly proliferated, eventually covering over 80% of the total
surface area by the end of 10 days. To avoid long-term studies in which endothelial cells
completely overwhelm osteoblast response, a low ratio of endothelial cells was chosen
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for further study. Thus, a 2% co-culture was utilized to test osteoblast-specific gene
expression.
Osteocalcin (a marker of late-stage osteoblast differentiation) gene expression
was decreased in osteoblast/endothelial cell co-cultures. While initially concerning, the
decrease in OCN may be explained by a prolonged state of proliferation in osteoblasts cocultured with endothelial cells. This has been seen in some studies (15,16), and would
explain reductions in late-stage markers of osteoblast differentiation as well as increases
in cell number associated with co-cultures. The increase in ALP would still be relevant,
as it is an early-stage marker of differentiation that peaks in expression well in advance of
genes such as OCN. If true, one would expect a subsequent peak of OCN to be several
days later than would normally be expected (17).

Future work should include a

timecourse of bone-specific gene expression with co-cultures of osteoblasts and
endothelial cells.
Ultimately, the goal is to produce bone matrix in a 3D construct.

An up-

regulation in ALP with co-cultures was encouraging, and supported the continued use of
our co-culture model.

Moving forward, we chose to use a 2% co-culture in three

dimensions to continue our tissue-engineering work. Although two-dimensional results
do not necessarily predict 3D results (18), expanding this co-culture model into three
dimensional constructs has the potential to advance the field of bone tissue engineering.
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CHAPTER SIX
3D Co-cultures
Perfusion flow enhances the infiltration of osteoblasts and endothelial cells into 3D
calcium phosphate scaffolds.
Matthew J. Barron, B.S., Jeremy Goldman, Ph.D., Seth W. Donahue, Ph.D.

Introduction
While autografts are currently the best available option for bone grafting, the pain
and morbidity associated with second surgeries combined with the limited availability of
autograft sources highlights the need for alternative grafting materials (1-3). An ideal
bone graft provides scaffolding for new bone tissue to grow into (osteoconductive),
induces host tissue to produce new bone matrix (osteoinductive), and supplies a cellular
source for new tissue growth (osteogenic) (3-6). Although 3D bone tissue engineering
can provide all three traits, one of the biggest limitations to overcome is the maintenance
of cellular viability within the center of 3D constructs upon in vivo implantation (7-11).
Proper vascularization is critical for successful bone growth and development,
and is one of the first phases seen during fracture healing (11-16). Without proper
vascularization, bone tissue would face limited growth and hypoxia (13).

As the

vasculature provides bone tissue with oxygen, nutrients, growth factors, and the removal
of waste, it is not surprising that vascularization is also essential for successful implant
integration. Currently, implanted bone grafts rely on the in-growth of existing vessels
from host tissue (7,9), which can take significant amounts of time, leading to poor
vascularization and implant rejection (7). One solution to this clinical problem is to
introduce tissue-engineered bone is pre-vascularized by a rudimentary vascular system
(7,9,10,17,18). A common approach to this solution is the co-culture of bone cells and
endothelial cells on three-dimensional constructs.
There has been some success with co-culturing bone cells and endothelial cells to
overcome the lack of vasculature in tissue-engineered bone (7-10,17-19). These studies
have shown that not only will endothelial cells form a pre-vascular network during co74

culture (9,10,17), but also that endothelial cells can augment osteoblastic activity when
both cell types are in direct contact (8,9,17,20,21). Additionally, recent work has shown
that 3D co-cultures will integrate with host tissue in vivo, with the formation of an
improved vascular network upon implantation (22-24).
Although static co-cultures have had some success, it is not known how a coculture model will respond to a dynamic environment. Perfusion bioreactors actively
deliver culture medium to cell-seeded porous scaffolds through pump-driven fluid flow.
Perfusion flow increases cellular viability and oxygen transport within osteoblast-seeded
3D constructs (25-30), leading to enhanced gene expression (25,27,31), protein
production (26,29,32-35), and calcium deposition (26,33,36-38). In addition, fluid flow
also activates endothelial cells, increasing angiogenic gene expression and the formation
of tube-like structures (12,20,39-42). Taken together, these results suggest that the use of
a perfusion bioreactor with osteoblast/endothelial cell co-cultures may accelerate the
vascularization of tissue-engineered bone.
We hypothesize that co-culturing osteoblasts and endothelial cells will increase
osteogenic and angiogenic gene expression in 3D calcium phosphate scaffolds.
Furthermore, perfusion flow will increase the length of endothelial cell aggregations in
3D porous scaffolds. This work will help elucidate the contributions of endothelial cells
to osteoblastic gene activity, as well as the effects that a dynamic environment has on the
formation of a vascular network in co-cultures.

Materials and Methods
Cell Culture
Mouse osteoblast-like cells (MC3T3-E1 subclone 4, ATCC, Manassas, VA) were
cultured in alpha-MEM (Invitrogen, Carlsband, CA) with 10% FBS (Hyclone, Logan,
UT) and 1% pen/strep (Cellgro, Herndon, VA). Mouse microvascular endothelial cells
(EC) (EOMA, ATCC, Manassas, VA) were cultured in dulbeccos-MEM (Invitrogen,
Carlsband, CA) with 10% FBS (Hyclone, Logan, UT) and 1% pen/strep (Cellgro,
Herndon, VA).

Once cells reached ~70% confluency, they were trypsinized, re-

suspended in culture medium, and statically seeded onto 3D calcium phosphate scaffolds
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(1,000,000 cells/scaffold; 98% osteoblasts, 2% endothelial cells) (BD Biosciences, San
Jose, CA). The scaffolds have an interconnected porosity of ~ 60% with an average pore
size of 200-400 microns. This is comparable to trabecular bone (50-90% porosity, 5001500 micron pore size (43)), and within the range suggested to be optimal for bone
regeneration (150 – 650 microns) in porous scaffolds (44). Samples were then incubated
for 1 hour to allow cell adhesion, covered with media, and incubated for 24 hours before
experimentation. During experimentation, osteoblast differentiation media was used by
adding 10 mM beta-glycerol phosphate and 50 mg/mL ascorbic acid.

Figure 18 - Bioreactor setup with only the syringe pump used for long-term perfusion
incubation. The linear actuator was not used for high-shear oscillatory fluid flow. See
text for more detail.
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Experimental Design
Four treatment groups were tested: two cell populations (osteoblasts alone and
osteoblast/endothelial cell co-culture) with two culture methods (static culture and
perfusion flow). Static samples were cultured in 24-well plates, while perfusion samples
were cultured in bioreactor chambers. All samples remained incubated at 37°C with 5%
CO2 for the duration of the experiment. Flow was initiated immediately after samples
were placed into the chambers and continued for the duration of the experiment. After 7
or 14 days of culture, samples were removed from static or perfusion incubation and
RNA was isolated, or samples were fixed in 10% buffered formalin for histological
processing. Gene expression was assessed after both time points (n=3 per group), and
histological analysis performed at 14 days (n=3 per group).

Perfusion Flow Bioreactor
A custom perfusion bioreactor was used to deliver culture media to osteoblasts on
calcium phosphate scaffolds. Each bioreactor chamber consists of a top and bottom
aluminum block, between which a polycarbonate block is secured (Figure 18). A 6-mm
hole was drilled out of the polycarbonate block to fit a porous calcium phosphate scaffold
5-mm in diameter and 3.5-mm in height (BD Biosciences, Bedford, MA). A 4-mm hole
was drilled through the center of all three blocks to allow fluid flow through the scaffold.
Grooves were machined around both the hole and the space on each side of the
polycarbonate block to fit a #11 Viton O-ring (Allorings, Hampton Falls, NH). A 1/8th
inch barbed pipe connector was threaded into both the top and bottom aluminum blocks
and connected to 1/8th inch silicone tubing (Harvard Apparatus, Holliston, MA). The
silicone tubing is permeable to CO2 and O2, permitting adequate gas exchange. Tubing
connected the top of the chamber to a 140 ml syringe fluid reservoir, and the bottom of
the chamber to syringe pump (Harvard Apparatus). The pump delivered media at a rate
of 0.075 ml/min, with flow being reversed every 24 hours. Media was replenished every
third day.
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RNA Isolation and RT-PCR
After 7 and 14 days of culture, cell-seeded scaffolds were placed in 2 ml tubes
and crushed in SV Lysis Buffer with a glass rod. After lysis, dilution buffer was added
along with 200 mM phosphate buffer to elute the RNA. RNA was isolated from cells
using the Promega SV total RNA Isolation kit according to manufacturer’s instructions.
RNA concentration and quality was determined using spectrophotometer (Nanodrop ND1000 spectrophotometer, Nanodrop Technologies, Rockland, DE) readings at 260, 230,
and 280 nm. Gel electrophoresis was used to verify RNA integrity. RNA was reverse
transcribed into cDNA using a reaction mix consisting of Superscript II reverse
transcriptase (Invitrogen, Calrsbad, CA), 1x first strand buffer (Invitrogen), 800 µM
dNTPs (Promega), Rnase out recombinant ribonuclease inhibitor (Invitrogen), 48 mM
dithiothreitol (Invitrogen) and 0.5 µg Oligo(dT)12-18 primer at 42°C for 20 minutes, 50°C
for 10 minutes and 42°C for 1 hour in the Mastercycler Gradient Thermocycler
(Eppendorf, Westbury, NY). cDNA was then used for real time PCR for the genes of
interest and the housekeeping genes (Table 8).
All reactions were performed in the StepOnePlus real-time PCR system (Applied
Biosystems) under the following cycle parameters: hot start at 95°C for 15 minutes
followed by 40 cycles of 95°C for 15 seconds, 60°C for 30 seconds and 72°C for 15
seconds. Threshold fluorescence was set to 1500 dR and the Ct value was determined for
all reactions. Ct values were used to determine the relative up or down regulation for
each gene using the relative standard curve method and normalizing to housekeeping
genes that do not change between treatments (45).

Histological Analysis
Preparation
Following fixation, 14-day samples were placed in cassettes, covered in OCT
freeze medium, and placed under vacuum for 48 hours to remove air bubbles. Samples
were then removed, flash frozen, and sectioned on a soft tissue microtome (Microm
International, Waldorf Germany) at a thickness of 10 microns. Sections were taken from
mid-way through the scaffold running parallel to the direction of perfusion flow (Figure
19). Sections were decalcified in 0.5% EDTA for 20 minutes. After washing with PBS,
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Gene Name

Function

Primer Sequence

Osteocalcin

Osteoblast
Differentiation

F: 5'- GAGTCTGACAAAGCCTTCATGTCC -3';
R: 5'- TGATAGCTCGTCACAAGCAGGGTTA -3'

Osteopontin

Osteoblast
Differentiation

F: 5'- CAGCTGGATGAACCAAGTCTGGAA -3';
R: 5'- ACTAGCTTGTCCTTGTGGCTGTGA -3'

Alkaline Phosphatase

Osteoblast
Differentiation

F: 5'-GCCCTCTCCAAGACATATA-3';
R: 5'-CCATGATCACGTCGATATCC-3'

RUNX-2

Osteoblast
Differentiation

F: 5'- AGAGTCAGATTACAGATCCCAGGC -3';
R: 5'- GTCAGAGGTGGCAGTGTCATCAT -3'

Collagen Type I

Matrix Protein

F: 5'- TGGTTTGGAGAGAGCATGACCGAT -3';
R: 5'- TGTAGGCTACGCTGTTCTTGCAGT -3'

Vascular Endothelial
Growth Factor A

Angiogenesis

F: 5'- ACAGAAGGAGAGCAGAAGTCCCAT -3';
R: 5'- ATGTGCTGGCTTTGGTGAGGTTTG -3'

VEGF Receptor 2

Angiogenesis

Cyclophillin

Housekeeping

5-CTC TGT GGG TTT GCC TGG CGA TTT TCT-3;
5-GGG GAT CAC CAC AGT TTT GTT CTT GTT-3
F: 5'- TCATGTGCCAGGGTGGTGACTTTA;
R: 5'- ATGCTTGCCATCCAGCCATTCAGT -3'

Beta-Actin

Housekeeping

F: 5'- ATCACTATTGGCAACGAGCGGTTC -3';
R: 5'- TCTCCTTCTGCATCCTGTCAGCAA -3'

Ubiquitin

Housekeeping

F: 5'- CGTCGAGCCCAGTGTTACCACCAAGAAGG -3;
R: 5'- CCCCCATCACACCCAAGAACAAGCACAAG -3'

Table 8 - Primer sequences and roles for genes measured in 3D co-culture study.
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Figure 19 - Sections were removed from the middle of the scaffold parallel to the direction of
flow. Nine sample regions from each section were used to quantify cell number, surface coverage,
and cell/matrix area coverage. Regions 1-8 are combined and are referred to as the scaffold
perimeter. Region 9 is referred to as the scaffold center.
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biotin-conjugated antibody (1:250 anti-mouse CD31 – Endothelial Cell specific) was
added and samples were incubated for 1 hour. Sections were again washed and the
secondary antibody (1:500, Alexa Fluor 755) was added and samples were incubated for
45 minutes. Following a brief rinse, sections were also stained with hematoxylin and
eosin. Prior to fluorescent microscopy, DAPI was added to the sections to identify cell
nuclei. Images were captured for the entire section from each sample at 100x total
magnification using both brightfield and fluorescent microscopy. Nine images were
taken in total, three from the upper, middle, and lower thirds of each section (Figure 19).
Fluorescent images were used to distinguish between cell types, as DAPI identifies all
cell nuclei and CD31 stains membrane receptors on endothelial cells. Brightfield images
were used to determine total cell number, surface coverage, and cell/matrix area
coverage.

Cell Number, Surface Coverage, Cell/Matrix Area Coverage
Cell number, surface coverage, and cell/matrix area coverage were determined
around the perimeter of the scaffold as well as in the scaffold center, allowing for the
assessment of whether perfusion flow is more effective in areas of poor diffusion. For
the scaffold perimeter, regions 1-8 were combined. For the scaffold center, only the
center image (region 9) was used for measurement (Figure 19).
Average cell number was determined by counting the total cell number in each
region within a section. In the scaffold perimeter, cell number was averaged for all 8
regions (Figure 19) for easier comparison with the scaffold center (region 9 – Figure 19).
Surface coverage (represented by % total perimeter) was calculated by measuring
the ratio of cell coverage around the surface area of scaffold pores to the total surface
area of scaffold pores (including outer surface) using Bioquant (Bioquant Osteo,
Nashville, TN) software. Since surface coverage was calculated as a percentage of total
coverage area, so averaging all 8 regions was not necessary to compare with the scaffold
center (region 9 – Figure 19).
Cell/matrix area coverage (represented as % pore space) was established by measuring
the ratio of cell and matrix area within pore spaces to total pore space using a standard
threshold value in Bioquant (Figure 20). Since cell/matrix area coverage was
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Figure 20 - To determine cell/matrix area coverage, a ratio was calculated between A) area of
cell/matrix coverage and B) total area of pore spaces. The area in red was used for
measurement and was determined by setting a threshold value in Bioquant.

calculated as a percentage of total coverage area, so averaging all 8 regions was not
necessary to compare with the scaffold center (region 9 – Figure 19).
To measure the length of endothelial cell aggregations, fluorescent microscopy
was used to distinguish between cell types, and Bioquant was used to determine
endothelial cell aggregate length based on standard scale measurements (Figure 21). The
number of endothelial cell aggregates was small due to the low ratio of endothelial cells
seeded initially. Thus, additional sections were taken from 25% and 75% of the way
through each sample for additional measurements of aggregation length.

Figure 21 - Fluorescent image of osteoblast/endothelial cell co-cultures - dapi stained nuclei (Blue)
and CD31 antibody (orange) for endothelial cells. White bracket designates aggregate length
measurement.
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Statistics
Gene Expression
Three samples were tested for each experimental condition.

A two-factor

ANOVA (cell population and incubation method) was used to establish model
significance.

Significance was established for both factors, so grouping was not

possible. JMP IN 5.1 statistical software package (SAS, Cary, NC) was used for all
statistical analyses.

Histological Analysis
A two-factor ANOVA (cell population and culture method) was used to establish
model effects for histological endpoints.

No significance was associated with cell

population (osteoblast vs. co-culture) for cell number (p = 0.94), surface coverage (p =
0.64), or cell/matrix area coverage (p = 0.43), and no interactions existed between factors.
Thus, values were combined for osteoblast and co-culture treatments. A one-factor
(ANOVA) was then used to compare cell number, surface coverage, and cell/matrix area
coverage between static culture and perfusion flow in both the scaffold perimeter (regions
1-8 combined) and the scaffold center (region 9) (Figure 19).
For endothelial cell aggregation length, each aggregation within a section was
measured. As the lengths within each biological replicate were normally distributed and
were not significantly (p = 0.33) different between samples within a treatment, a one-way
ANOVA was run comparing all aggregation lengths within static culture to all
aggregation lengths within the perfusion flow treatment. JMP IN 5.1 statistical software
package (SAS, Cary, NC) was used for all statistical analyses.

Results
Gene Expression
Incubation Method - Perfusion Flow vs. Static Culture
After 7 days of culture, mRNA levels of both ALP and OCN were up-regulated
(over static culture) by 2.4 fold (p = 0.0003) and 10.0 fold (p = 0.0009), respectively,
when cultures (osteoblast cultures and co-cultures combined) were exposed to perfusion
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flow (Table 9). This was not surprising, as ALP and OCN, both markers of osteoblast
differentiation, have been shown in several instances to be increased in 3D scaffolds
exposed to perfusion culture (25,26,33,37,46). RUNX-2, OPN, Col1, and VEGF did not
change (p > 0.2).
Gene

7-Day Fold Change p-value 14-Day Fold Change p-value

ALP

↑2.4

0.0003 NC

0.11

OCN

↑10.0

0.0009 NC

0.91

RUNX-2

NC

0.26

↓ 0.58

0.0004

VEGF

NC

0.55

↓ 0.85

0.003

Table 9 - Changes in mRNA levels with perfusion flow. P-values represent model effects for
incubation method (osteoblast cultures and co-cutlures combined).

After 14 days of culture, perfusion flow down-regulated mRNA levels of RUNX2 and VEGF by 0.58 (p = 0.0004) and 0.85 fold (p = 0.003), respectively. These results
were unexpected as both genes have been shown to be up-regulated as osteoblasts
differentiate, and 7-day mRNA levels indicated an increase in differentiation-related
genes (ALP and OCN).
Cell Population – Osteoblast Culture vs. Endothelial Cell/Osteoblast Co-culture
Co-culturing endothelial cells with osteoblasts (static and perfusion combined)
caused changes in only one gene at either time point. After 14 days of culture, RUNX-2
was down-regulated in co-cultures by 0.17-fold (p = 0.0024) over osteoblasts alone. No
other changes were evident (p > 0.2).
Histological Analysis – Cell Number, Surface Coverage, Cell Area Coverage
Under static culture, cell number was 60% lower (p = 0.003) in the scaffold center
(region 9) as compared to the scaffolds’ outer perimeter (regions 1-8) (Figure 22).
Surface coverage and cell/matrix area coverage were not significantly different (p >
0.45).
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Average Cell Number per
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Figure 22 - Cell Number is Lower in the Middle Region of 3D Scaffolds Cultured Statically
for 14 Days

Around the scaffold perimeter, perfusion flow had no effect on cell number (p =
0.09), surface coverage (p = 0.58), or cell/matrix area coverage (p = 0.06). However, in
the scaffold center perfusion flow increased cell number (p = 0.03), surface coverage (p =
0.02), and cell/matrix area coverage (p = 0.03) by 220%, 84%, and 280% respectively
compared to static culture (Figures 23-25). These findings suggest the scaffolds’ centers
are more responsive to perfusion flow than the outer perimeter.

These results are

consistent with both literature and our hypothesis.

Average Cell Number per
Region
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600

Perfusion
p = 0.09

p = 0.03
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300
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0
Scaffold Perimeter

Scaffold Center

Figure 23 - Cell number is increased in 3D scaffolds when exposed to perfusion flow for 14
days
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Figure 24 - Surface coverage is increased in 3D scaffolds when exposed to perfusion flow
for 14 days
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Figure 25 – Cell/matrix area coverage is increased in 3D scaffolds when exposed to
perfusion flow for 14 days
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Histological Analysis – Endothelial Cell Aggregate Length
Qualitative Observations
Endothelial cells were found along the surfaces of the scaffold pores rather than
within the matrix formed by osteoblasts inside the pore structures. Additionally, EC
aggregations were found in all 9 sample regions of the scaffold, and did not appear to be
more highly concentrated in any particular region of the scaffolds.

Furthermore,

endothelial cells were not found as individual cells, but rather as aggregations of many
cells. This was true throughout all regions. Aggregations seemed to be oriented in all
directions on the scaffold surface, and did not tend to be aligned in the direction of fluid
flow.

Endothelial Cell Aggregate Length
Aggregations were measured from each region of the scaffold sections. The
number of aggregations in each region varied considerably, and there was no difference
in the average aggregate number (p = 0.31) in the scaffold perimeter and the scaffold
center. Furthermore, there was no difference (p = 0.20) in aggregate number between
static culture and perfusion flow (Figure 26). However, the average endothelial cell
aggregate length increased by almost 50% (p = 0.007) in perfusion flow samples
compared to static samples (Figure 27). There was no difference in total endothelial cell

Average Number of
Endothelial Cell Aggregates

aggregate length in static culture vs. perfusion flow (Figure 28).
50

p = 0.20

40
30
20
10
0
Static

Perfusion

Figure 26 - The average number of endothelial cell aggregates did not change in 3D
scaffolds subjected to perfusion flow compared to static conditions.
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Figure 27 - The average length of endothelial cell aggregates was increased in cell-seeded
3D scaffolds and exposed to perfusion flow (n = 72 aggregates) compared to static
conditions (n = 114 aggregates).
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Figure 28 - Total Length of Endothelial Cell Aggregations Does Not Change With Perfusion Flow

Discussion
The ultimate goal of tissue engineering is to produce high quality bone tissue in
vitro to be used as a clinical alternative to autografting. 3D structures cultured in vitro
encounter limited vascular invasion upon implantation. Here, we co-cultured endothelial
cells and osteoblasts to develop a method which might improve vascularization following
implantation of tissue-engineered bone constructs in vivo.

Specifically, we used

perfusion flow to increase the length of endothelial cell aggregations within co-cultures
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while at the same time increasing osteoblast-specific gene expression and the cell
number, perimeter coverage, and cell area coverage in the center of the scaffold.
Although there is no existing literature on the effects of perfusion flow on cocultures, there have been studies which have achieved vascular-like network formation in
static osteoblast/endothelial cell co-cultures (10). While we showed that perfusion flow
can increase the length of EC aggregations, we did not provide evidence of the formation
of vascular-like networks among EC populations. The process of how the endothelial
cells tended to aggregate within the scaffold was not established as our priority was to
determine aggregation length rather than method of formation. It is possible that ECs
proliferated and continued to align themselves along the perimeter of the scaffolds’ pores,
rather than actively migrating together. This method of formation seems likely as we did
not observe any network formation between aggregations, nor did we identify any
individual endothelial cells outside of major aggregations. The low ratio (2%) of
endothelial cell seeding may not have allowed for communication between populations of
endothelial cells, which is necessary for network formation. In the future, it may be
necessary to increase the ratio of endothelial cells to increase interaction between
aggregations, enhancing network formation.
In static culture, the center region of the scaffolds had lower cell number than in
peripheral regions. Perfusion flow successfully increased cell number as well as scaffold
perimeter coverage and cell area coverage in the scaffold center. These three responses
were not seen along the scaffold perimeter. This amplified response within the center of
the scaffold may be explained by considering diffusional limitations associated with 3D
tissue engineering (4,30,47,48). 3D cell-seeded constructs have reduced cell numbers
and cellular activity towards their centers due to poor nutrient and oxygen delivery.
Perfusion flow has been used to mitigate these limitations by increasing oxygen and
nutrient delivery (30), consequently increasing cell number, matrix production, and
osteoblast-specific gene expression in the center of 3D constructs. Thus, it is not
surprising that perfusion flow affected the scaffolds’ center to a greater degree than it did
the scaffolds’ outer perimeter.
In attempting to develop vascular rudiments with osteoblast/endothelial cell cocultures, we also demonstrated that co-culturing decreases RUNX-2 gene expression in
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osteoblasts, suggesting that co-culture may slow the process of differentiation in
osteoblasts, as has been seen in other studies (49).

Despite this decrease in gene

expression, there was no histological evidence of reduced cell number, perimeter
coverage, or area coverage with co-culture.
Our results indicate that perfusion flow increases bone specific gene expression of
ALP and OCN at seven days, which is consistent with previous reports (25,26,33).
Furthermore, histological evidence suggests that osteoblast activity is increased with
perfusion flow. In contrast to these results, RUNX-2 was reduced with perfusion flow
after 14 days of culture. Osteoblast differentiation genes tend to follow a well-defined
pattern of expression throughout the process of maturation. ALP, OCN, and OPN are all
up-regulated transiently, tend to peak after 2-3 weeks, and subsequently drop in
expression as osteoblasts differentiate into osteocytes. As RUNX-2 is a transcription
factor responsible for osteoblast differentiation, it is not surprising that its expression
precedes osteoblast-specific genes. A possible explanation for the decrease in RUNX-2
expression with perfusion flow is that it has reached its peak expression earlier in
perfused samples, and has already begun its decline in expression at 14 days. Future
research may include a timecourse to fully understand the expression patterns of
osteoblast-specific genes.
Previous research has shown that perfusion bioreactors reduce hypoxia in 3D
scaffolds (26,30,33). Hypoxia elicits a well-documented response from mesenchymal
stem cells and osteoblasts, including the up-regulation of vascular endothelial growth
factor (VEGF), a major mediator of both angiogenesis and hypoxia (50,51). Here, we
have shown that perfusion flow reduces the expression of VEGF in osteoblast and cocultures seeded on 3D scaffolds. In addition, cell number, scaffold perimeter, and cell
area coverage are all increased in the scaffold center with perfusion flow.

Taken

together, it is reasonable to hypothesize that perfusion flow mitigates hypoxic conditions
by providing adequate oxygen and nutrient delivery to the center of 3D constructs. Thus,
although VEGF is up-regulated in differentiated osteoblasts, the reduction in VEGF with
perfusion flow may provide evidence that the role of VEGF in hypoxia may supersede its
role in osteoblast differentiation.
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The increase in endothelial cell aggregation length highlights the potential for
perfusion bioreactors in 3D bone tissue engineering. By increasing the in vitro activity of
ECs in bone tissue constructs, perfusion flow could serve to speed up the process of host
acceptance in future clinical applications. A higher quality vascular-like network in vitro
will have a greater likelihood of attaining successful anastomosis with host vasculature in
vivo. Even if functional anastomosis isn’t realized, perfusion-induced EC activity could
potentiate paracrine signaling between cells within the scaffold and host vasculature,
advancing vascular infiltration.
Our results support the continued use of perfusion bioreactors to culture 3D bone
tissue constructs. Perfusion flow increased osteoblast mRNA production, cell number,
and cell coverage area. Furthermore, perfusion flow stimulated an increase in endothelial
cell aggregation length in osteoblast/endothelial cell co-cultures. These results support
the use of perfusion bioreactors to improve in vitro co-culturing in order to maximize the
quality and effectiveness of vascularized bone tissue cultures.
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CHAPTER SEVEN
Conclusions
Summary
3D bone tissue-engineering is constrained both in vitro and in vivo by limited
cellular viability. In vitro, large 3D structures experience reduced osteogenic activity in
their centers due to diffusional restrictions (1-10).

In vivo, 3D tissue-engineered

constructs are faced with limited vascular infiltration after implantation, resulting in
cellular apoptosis (11,12). While perfusion bioreactors show promise for increasing
cellular viability and osteogenic activity in vitro (1-8), it remains unclear how mechanical
stimulation contributes to long-term 3D cultures.

In addition to improving culture

conditions for 3D structures in vitro (Chapters 4 and 6), perfusion flow also increased the
length of endothelial cell aggregations (Chapter 6), which could lead to improved
vascular integration upon in vivo implantation.
Though partitioning mechanical stimulation did not establish an increase in
osteogenic response, initial experimentation did provide significant, although unexpected,
results. OPN gene expression was reduced when osteoblasts cultured on 3D calcium
phosphate scaffolds were exposed to high-shear oscillatory fluid flow for 24 hours
(Chapter 3), which contrasts 2D results. Furthermore, OPN, VEGF, and HIF-1α gene
expression was reduced when osteoblasts cultured on 3D scaffolds were exposed to a
constant rate of low-shear perfusion flow (24 hours for OPN and VEGF, 48 hours for
HIF-1α) (Chapter 4). Literature suggests that OPN gene expression is increased by
mechanical stimulation (7,8,13-16), but there is also evidence that OPN is increased
under hypoxic conditions (17-19). I believe that in our model, OPN’s role in hypoxia
may supersede its response to mechanical stimulation. Supporting evidence includes the
reduction in both VEGF and HIF-1α (major mediators that are increased with hypoxia),
as well as increases in osteoblast infiltration (Chapter 4), cell number, scaffold perimeter
coverage, and cell area coverage in osteoblasts cultured with perfusion flow (Chapter 6).
Future work must consider the extent of induced hypoxia in our 3D constructs.
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Increased vascular-like structure in 3D in vitro scaffolds may accelerate construct
integration upon in vivo implantation.

As perfusion flow increased the length of

endothelial cell aggregations, the use of perfusion bioreactors to improve vascular-like
networks in co-cultures is promising. Future studies are necessary to better characterize a
co-culture model that could maximize matrix deposition as well as vascular network
formation.

Key Findings
Partitioning mechanical stimulation does not alter gene expression in comparison
to a single bout.
Gene expression of OPN and FGF-2 is up-regulated in 3D compared to 2D, while
Collagen 1 gene expression is down-regulated.
Mechanical stimulation increases OPN in 2D culture at 48 hours, but decreases
OPN in 3D culture.
Perfusion flow decreases hypoxia-induced genes: VEGF, HIF-1α, OPN.
ALP is up-regulated, and OCN and down-regulated in 2D osteoblast/endothelial
cell co-cultures. 3D co-cultures did not provide similar results.
ALP and OCN gene expression is up-regulated in long-term osteoblast cultures
exposed to perfusion flow.
VEGF expression is reduced with perfusion flow in long-term osteoblast cultures.
Cell number, scaffold perimeter coverage, and cell area coverage are all increased
in the center of 3D scaffolds cultured long-term, but are not increased around the
scaffold perimeter.

Limitations
One of the biggest limitations of this dissertation is that many of the conclusions
are drawn from gene expression data. While this data is critical to fully understanding
signal transduction in 3D cultures, transcription does not necessarily guarantee
translation. Thus, while gene expression may be altered, protein production may not
change. However, the final study (see Chapter 6) included histological evidence that
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supports many of the conclusions drawn from gene expression data. None-the-less, it
would be of interest to establish gene and protein expression along with matrix
production and calcium deposition to chronicle patterns of bone growth in a 3D in vitro
environment.
One recognized limitation of our study involving 2D vs. 3D is the disparity in
substrates between models. With glass as the substrate in our 2D model, and calcium
phosphate as the porous scaffold in our 3D model, it is possible that some of the changes
in gene expression are due to differences in material characteristics, rather than
architecture as we believe. To truly understand the differences that material properties
have on gene expression, it will be necessary to design experiments controlling for
architecture.
In Chapter 6, we sought to test the effects of co-culture on gene expression in our
3D model. Our results suggested that co-culturing decreases OPN and RUNX-2 gene
expression in osteoblasts cultured in 3D as well as OCN gene expression in 2D (results
not shown), suggesting that co-culture may indeed slow the process of differentiation in
osteoblasts. However, there is no histological evidence of changes in OB activity, as cell
perimeter, area, and number were not significantly different and showed no distinct
trends between co-cultures and osteoblasts alone.

Nevertheless, these histological

measures may not be the best indication of osteoblast differentiation. Unfortunately, one
of the best measures of osteoblast maturation is the deposition of calcium, which is best
measured analytically. As our scaffolds consist of calcium phosphate, any changes in
calcium deposition would be extremely difficult to measure. Furthermore, it was not
possible to measure calcium deposition histologically, because we were unable to
determine the difference between the scaffold and fresh calcium deposits.
While it was exciting to show an increase in endothelial aggregation length, we
were not able to provide evidence of the formation of vascular-like networks among
endothelial cell populations. It is possible that rather than migrating together (as has been
shown in literature), endothelial cells proliferated in “nodes” to align themselves along
the perimeter of the scaffolds’ pores. This method of formation seems likely as we did
not observe any network formation between aggregations, nor did we identify any
individual endothelial cells outside of major aggregations. Furthermore, we found no
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evidence of the formation of a vessel lumen within aggregations, diminishing the hope
for functional anastomosis with native bone.

However, even if anastomosis upon

implantation is not achieved, the incorporation of EC’s into 3D cultures may still improve
vascularization through paracrine signaling activity between cells within the scaffold and
host vasculature.

Future Direction
Mechanical Stimulation in 2D and 3D
It is clear that differences do exist between 2D and 3D cultures, suggesting that
data collected in 2D studies cannot necessarily be extrapolated to a 3D environment.
Furthermore, mechanical stimulation can have different effects in 2D vs. 3D, highlighting
the importance of future experimentation on mechanotransduction in 3D culture.
Responses to mechanical stimulation may be partially driven by factors such as
architecture, which cannot be completely accounted for in 2D cultures. Future research
must focus on controlling the parameters of a 3D grafting structure, and comparing 2D
and 3D cultures under dynamic conditions.

The Role of OPN
Mechanical stimulation and perfusion flow both reduced the gene expression of
OPN, which is generally thought to be a marker of osteoblast differentiation in long-term
3D cultures. As such, it was surprising that early time points showed a significant
decrease in its expression.

Knowing that OPN also plays a major role in the

inflammatory response as well as a role in hypoxia, it would be prudent to study OPN
more carefully, including a time course to elucidate its role in 3D cultures. Considering
our results, it is possible that different mechanisms may drive OPN gene expression in
3D cultures.

Vascular Network Formation in 3D Co-cultures
The

formation

of

a

vascular

osteoblast/endothelial cell co-cultures.

network

was

not

achieved

in

3D

As stated earlier, it is more likely that ECs
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proliferated and continued to align themselves along the perimeter of the scaffolds’ pores
to form aggregates, rather than actively migrating together as is seen in other models.
The low ratio (2%) of endothelial cell seeding may not have allowed for communication
between populations of endothelial cells, which is necessary for network formation. In
the future, it may be necessary to increase the ratio of endothelial cells to increase
interaction between aggregations, enhancing network formation.
Another potential reason for the lack of network formation is the cell type. While
the EOMA cell line has provided a good benchmark, primary cell lines may prove to
form more mature vascular-like networks.

Vascular Anastomosis
Ideally, a vascularized tissue-engineered bone construct would enhance
anastomosis between the vascular network provided by the 3D implant and the host’s
vascular supply, forming functional connections. While this has seen limited success in
vivo, future research should include in vivo implantations of vascularized constructs
enhanced by perfusion flow. Even if functional anastomosis isn’t realized, perfusioninduced endothelial cell activity may paracrine signaling between cells within the
scaffold and host vasculature, advancing vascular infiltration despite a lack of a
functional association.

Hypoxia
Evidence supports the hypothesis that perfusion flow reduces hypoxic conditions
in 3D tissue-engineered scaffolds. Down-regulation of hypoxia-specific genes, as well as
increases in cell number, perimeter coverage, and cell area coverage in the center of 3D
scaffolds all suggest that perfusion flow provides delivery of oxygen and nutrients to
starved cells. However, future research must directly measure whether hypoxia exists in
the center of in vitro scaffolds. Existing literature suggests that 3D structures do indeed
experience hypoxia, but our model must be tested to determine whether hypoxic
conditions exist, and the extent of rescue that perfusion flow provides.
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